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Chapter 1 
 
1.1 Introduction 
Addition reaction is one of the most efficient and useful methods to introduce 
many functional groups and substituents to two atoms of unsaturated molecules. 
Useful organic molecules, such as drugs, bioactive molecules, agrochemicals and 
organic functional materials, can be synthesized by the addition reactions. 
Unfortunately, two regioisomers are often formed in the process of operation, if 
less-polarized and/or less sterically differentiated C‒C multiple bonds are used as 
acceptors of the addition reactions. Therefore, the development of highly 
regioselective addition reactions is extremely desirable. 
 
1.2 Hydroarylation of Unsaturated Molecules 
Formation of C-C bonds is a core issue in synthetic organic chemistry. A useful 
method for the formation of aromatic C-C bonds is palladium- or nickel-catalyzed 
cross-coupling reactions between aryl halides (or pseudohalides) and various 
organometallic reagents, that is, Suzuki-Miyaura, Stille, Kumada-Tamao, Negishi, and 
Mizoroki-Heck cross-coupling reactions. However, these transition metal-catalyzed 
cross-coupling reactions can be realized by prefunctionalizations, such as 
halogenation and triflation of aromatic substrates. Therefore, several steps are 
required to synthesize the desired products. 
A C-H bond is one of the most basic chemical bonds that constitute organic 
compounds. Because of its high bond energy, stability, and resistance, it is usually 
difficult to promote chemical reactions of C-H bonds (Table 1.1).[1] The C–H bond 
activations have recently been received much attention as ideal transformations. 
Compared to conventional methods involving cross-coupling reactions, C–H 
transformations require fewer reaction steps to obtain target molecules and can 
enhance the atom economy.[2] Therefore, effective activation of inert C-H bonds and 
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development of novel, efficient, and environmentally friendly methods to construct 
C-C bonds are hot topics in synthetic organic chemistry.  
 
 
 
A report from Fujiwara group is the earliest research in this area. In 1967, they 
reported that styrene reacted with benzene to yield stilbene in the presence of one 
equivalent of PdCl2 (Scheme 1.1).
[3] Then in 1969 they further found Pd(OAc)2 to be a 
more efficient catalyst.[4] 
 
 
 
The first practical hydroarylation of unsaturated molecules via C-H activation 
was reported by Murai in 1993 (Scheme 1.2).[5] The C-H bonds in aromatic groups 
are cleaved by a ruthenium complex to give the addition products. The reaction 
proceeded efficiently and selectively. 
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The γ-C(sp3)-H olefination of aliphatic amides has been achieved under 
palladium catalysis (Scheme 1.3).[6] The use of a combination of a quinoline-based 
ligand and a weakly coordinating amide directing group is important to promote the 
reaction. The reaction provided a new method for constructing highly functionalized 
quaternary carbon centers at the β-position of aliphatic acids. 
 
 
 
A practical and efficient rhodium-catalyzed aerobic C–H activation for the facile 
synthesis of a broad range of 2,3-disubstituted indoles from simple anilines and 
alkynes has been developed (Scheme 1.4).[7] Environmentally friendly oxygen was 
employed as the sole clear oxidant to oxidize the Rh(I) to Rh(III) species in the 
presence of an appropriate acid. 
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Although the pioneering synthesis of an ortho-nickelated complex[8] via C–H 
bonds activation has been reported, there was no example of a nickel-catalyzed C-H 
transformation. A nickel-catalyzed synthesis of isoquinoline derivatives through 
chelation assistance and oxidative cycloaddition between aromatic amides and 
alkynes was achieved (Scheme 1.5).[9] 
 
 
 
In 2010, cobalt-catalyzed addition reactions of 2-arylpyridines and aromatic 
imines to unactivated internal alkynes to give trisubstituted alkenes with high regio- 
and stereoselectivities using a catalytic system consisting of a cobalt salt, phosphine 
ligand, and Grignard reagent (Scheme 1.6).[10] 
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In the case of hydroarylation reactions using less polarized and/or less sterically 
differentiated C‒C multiple bonds, two regioisomers are generally formed. For 
example, a nickel-catalyzed synthesis of 3,4-disubstituted isoquinolines between 
alkynes and aromatic imines afforded a mixture of isoquinolines (Scheme 1.7).[11] 
 
 
 
1.3 Difunctionalization of Unsaturated Molecules 
More than 50 years ago, researchers in Wacker Chemical Corporation found that 
alkenes were converted to aldehydes and ketones in the presence of palladium 
chloride as a catalyst and copper chloride as an oxidant in an aqueous phase (Scheme 
1.8).[12] Nowadays, palladium-catalyzed Wacker reactions are successfully applied to 
the industrial manufacture of acetaldehyde. In addition, a silver-catalyzed epoxidation 
of ethylene is also an important commercial synthetic route for ethylene oxide, which 
is a chemical raw material. Transition metal-catalyzed functionalization of alkenes 
have sprung up like mushrooms after rain owing to painstaking research works. 
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Transition metal-catalyzed difunctionalization of alkenes is also an important 
subject because two new functional groups can be brought into unsaturated molecules 
in only one step to efficiently construct highly functionalized structures of 
pharmaceuticals and natural products.[13] 
Mechanistically, difunctionalization of alkenes can be divided into two 
categories: radical and metal-catalyzed nucleophilic difunctionalizations, respectively. 
The radical difunctionalization begins with the addition of a radical to a C-C double 
bond to give intermediate A, which is trapped by extrinsic radical species to provide 
the product or oxidized to carbocation B (Scheme 1.9).[14] Subsequently, nucleophilic 
attack of the extrinsic nucleophile to generate difunctionalization product. By the way, 
carbocation B also undergoes β-H elimination to give alkylated alkene. 
 
 
 
Lei developed a copper-catalyzed radical carboxygenation of styrenes with alkyl 
bromides as a radical resource (Scheme 1.10).[15] Both the alkylation and alkoxylation 
of styrenes occur under catalytic radical difunctionalization in one pot. A wide range 
of styrenes and alcohols are well compatible under the reaction conditions. The result 
of EPR experiment indicates that alkyl halides could oxidize Cu(I) to Cu(II) in this 
transformation. 
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The first visible light-driven three-component oxytrifluoromethylation of alkenes 
was described by Akita using photoredox Ir catalysis (Scheme 1.11).[16] The choice of 
the Umemoto’s reagent is a key to promote the reaction. Nucleophiles, such as water, 
alcohols, and carboxylic acids, are suitable to provide highly efficient and 
regioselective oxytrifluoromethylated products under the irradiation of a 
light-emitting diode (LED) lamp even on natural sunlight. 
 
 
 
Zou achieved a novel hydroxysulfurization of styrenes with arylthiols in the 
presence of 0.5 mol% TBHP as a catalyst and green air (O2) as a sole oxidant 
(Scheme 1.12).[17] The various hydroxysulfurizated products can be obtained 
effectively, simply and conveniently, even on scaled up in a one-pot process without 
other additives. 
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Radical azidooxygenation of various alkenes is described using an easily 
prepared N3-iodine(III) reagent as N3 source and mild organic reducing reagent, 
TEMPONa (Scheme 1.13).[18] The reaction proceeded to give azidated products in 
good to excellent yields. Furthermore, cyclic systems delivered azidooxygenated 
products with excellent diastereoselectivity. 
 
 
 
In difunctionalization of non-polarized and/or less sterically differentiated 
alkenes, two regioisomers are sometimes formed. For example, the addition of DBPA 
to an alkene gave a 1:1 mixture of the corresponding adducts (Scheme 1.14).[19] 
 
 
 
As mentioned above, not only is hydroarylation faced with a regioselective 
problem but also difunctionalization of unsaturated molecules. For solving this 
problem, in the doctor course thesis, I developed rhenium-catalyzed synthesis of 
1,3-diiminoisoindolines via C-H bond activation (Chapter 2) and iron-catalyzed 
acyloxyalkylation of styrenes via decarboxylation of hypervalent iodine(III) reagents 
(Chapter 3). 
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Chapter 2 Rhenium-Catalyzed Synthesis of 
1,3-Diiminoisoindolines via Insertion of Carbodiimides into 
a C-H Bond of Aromatic and Heteroaromatic Imidates 
 
2.1 Introduction 
Rhenium is a manganese-group, sixth-period, transition metal (Group 7) in the 
same group with manganese, technetium, and bohrium in the periodic table. The 
electronegativity of rhenium is lower than late transition metals, such as ruthenium, 
rhodium, and palladium. Therefore, Re–X (X = C, N, O) bonds are more polarized 
than other M–X bonds of late transition metals. In other words, the Re–X bond in 
rhenium complexes or intermediates has relatively strong nucleophilicity, and the 
complexes or intermediates can react with polar unsaturated molecules.[1-2] 
 
2.2 Precedents of Rhenium-Catalyzed C-H Bond Transformations 
Rhenium(I) carbonyl complexes also catalyze C(sp2)-H bond functionalization 
(Scheme 2.1).[3] In 2005, Kuninobu and Takai successfully reported synthesis of 
aminoindene derivatives from aromatic aldimines and alkynes using a rhenium 
complex [ReBr(CO)3(thf)]2 as a catalyst. It proceeds via the following steps: (1) 
coordination of a nitrogen atom of the imino group to a rhenium center; (2) C-H bond 
activation to form an ortho-metalated intermediate; (3) insertion of an alkyne into a 
rhenium-carbon bond to give an alkenyl-rhenium intermediate; (4) intramolecular 
nucleophilic attack to a carbon atom of the imino group; and (5) reductive elimination 
and 1,3-rearrangement of the hydrogen atom. 
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In 2006, Kuninobu and Takai group described a cyclization reaction from 
aromatic ketimines and acrylates, and indene derivative was obtained in 85% yield in 
the presence of catalytic amounts of [ReBr(CO)3(thf)]2 (Scheme 2.2).
[4] In this 
reaction, a C=N double bond plays a role as both a directing group for C-H bond 
activation and an acceptor of the cyclization. 
 
 
 
When acetophenone was used instead of the ketimine in the presence of a 
catalytic amount of [ReBr(CO)3(thf)]2/p-anisidine cocatalyst in toluene at 180 °C for 
24 h gave the desired indene derivative in 93% yield (Scheme 2.3).  
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The rhenium complex [ReBr(CO)3(thf)]2 can be employed as a catalyst to 
promote insertion of polar unsaturated molecules, such as isocyanates and aldehydes, 
into a C-H bond of aromatic compounds to form phthalimidine and isobenzofuran 
derivatives (Scheme 2.4).[5-6] 
 
 
 
The formed isobenzofuran derivatives can be trapped easily by (Z)-cyclooctene 
via Diels–Alder reaction (Scheme 2.5).[7] Naphthalene derivatives were formed by 
dehydration under acidic conditions without isolation.[8] 
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Synthesis of indenone derivatives was achieved using 3 equivalents of aryl 
aldehydes under rhenium/amide catalysis (Scheme 2.6).[9] This reaction is a new 
synthetic route to construct indenones via rhenium-catalyzed three-component 
annulation. The rhenium catalyst plays as both a catalyst for C-H bond transformation 
and a Lewis acid. 
 
 
 
The rhenium complex [ReBr(CO)3(thf)]2 also activates heteroaromatic C-H 
bonds. Notably, the insertion of isocyanates into a C-H bond of heteroaromatic 
compounds occurs regioselectively (Scheme 2.7).[10] 
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Rhenium complexes also catalyze olefinic C-H bond functionalization. When 
[ReBr(CO)3(thf)]2 is used as a catalyst, insertion of polar unsaturated molecules into 
an olefinic C-H bond occurs to give γ,δ-unsaturated carbonyl compounds (Scheme 
2.8).[11] 
 
 
 
2.3 Precedents of Synthesis of 1,3-Diiminoisoindolines 
A 1,3-diiminoisoindoline skeleton is a partial structure of phthalocyanines and 
their metal complexes, which are useful as organic functional materials, such as 
pigments, organic electroluminescence, and organic field effect transistors (Figure 
1.1).[12] In addition, 1,3-diiminoisoindolines and their derivatives show biological 
activities as complement component antagonist[13] and antimalarial candidates.[14] 
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Several reactions to synthesize 1,3-diiminoisoindolines have been reported. 
These reactions, however, require harsh reaction conditions and only symmetrical 
1,3-diiminoisoindolines are obtained (Scheme 2.9).[15-16] Therefore, it is necessary to 
develop a new method for the synthesis of 1,3-diiminoisioinolines. Synthetic reactions 
of 1,3-diiminoisoindolines are, however, still rare. In addition, synthesis of 
unsymmetrical 1,3-diiminoisoindolines is still difficult. 
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2.4 Research Purpose 
Our group recently reported a rhenium-catalyzed synthesis of 
3-iminoisoindolinones using aromatic imidates and isocyanates. Due to the methoxy 
leaving group, a C=N double bond of the directing groups remains after the reaction 
(Scheme 2.10).[17] I investigated several reactions of imidates with other unsaturated 
molecules, such as carbodiimides. As a result, I found that a rhenium complex 
catalyzed a reaction between aromatic imidates and carbodiimides to give 
1,3-diiminoisoindolines efficiently. 
 
 
 
I began my studies with several transition metal complexes and salts using 
aromatic imidate 1a and N,Nʹ-diisopropylcarbodiimide 2a as model substrates. A 
rhenium complex, Re2(CO)10, exhibited high catalytic activity. Treatment of 1a with 
2a in the presence of Re2(CO)10 catalyst in chlorobenzene at 170 °C for 24 h gave 
1,3-diiminoisoindoline 3a in 99% yield (Scheme 2.11). I also checked several other 
transition metal complexes for the annulation reaction, but their reactivity shows low 
efficiency.[18] 
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(E)-N-((E)-5-Bromo-2-isopropyl-3-(isopropylimino)-1-isoindolinylidene)-1-prop
anamine 3A was employed to investigate nuclear Overhauser effect experiments (see 
experimental section for details) for confirming the stereochemistry of the imino 
groups (Scheme 2.12). These protons, Ha and Hb, Hc and Hd, are positive correlation, 
so I confirmed that the configuration of these imino groups are E. 
 
 
 
Interestingly, the by-product, methanol, fails to add to carbodiimide 2a. Previous 
results show that methanol can add to carbodiimide.[19]  
I then investigated the scope of aromatic imidates 1 in the rhenium-catalyzed 
annulation reaction with N,Nʹ-diisopropylcarbodiimide 2a (Table 2.1). A reaction of 
aromatic imidate with a phenyl group on the nitrogen, 1b, proceeded well to give the 
expected 1,3-diiminoisoindoline 3b in 85% yield. Functional groups, such as -OMe, 
-CF3, -MeO2C, -Br and -Ph, were tolerated and the desired products were obtained in 
excellent yield. Two regioisomers, 3h and 3hʹ, were observed when an aromatic 
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imidate with a methyl group at the meta-position 1h. In this reaction, 3h is the major 
product because of the sterically less hindered site. The desired reaction also 
proceeded regioselectively when naphthyl imidate 1i and heteroaromatic imidates 1j 
and 1k were used as substrates. 
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Next, I examined the substrate scope of carbodiimides (Table 2.2). Under the 
optimized reaction conditions, a reaction of dicyclohexylcarbodiimide (2b) with 1a 
afforded the corresponding 1,3-diiminoisoindoline 3l in 90% yield. Better results were 
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obtained for carbodiimides bearing primary alkyl groups, 2c-2e to afford 
1,3-diiminoisoindolines 3m-3o in 82%-94% yields without loss of the functional 
groups. Gratifyingly, reactions of dibenzylic carbodiimides proceeded smoothly and 
provided desired 1,3-diiminoisoindolines 3p and 3q in good yields. Interestingly, the 
regioselectivity was completely controlled in the reaction between 1a and 
unsymmetric carbodiimide 2h, and a single product 3r was produced. Diaryl 
carbodiimide 2i gave the corresponding 1,3-diiminoisoindoline 3s in 83% yield (E/Z = 
5:1). 
This reaction is the first example of transition metal-catalyzed insertion of a 
carbodiimide into a C-H bond of aromatic and heteroaromatic compounds and a novel 
example of the synthesis of an unsymmetric 1,3-diiminoisoindoline derivative. 
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A proposed mechanism for the formation of 1,3-diiminoisoindolines 3 is shown 
in Scheme 2.13: (1) oxidative addition of aromatic imidate 1 to a rhenium catalyst 
(C-H bond activation); (2) insertion of carbodiimide 2 into the formed 
rhenium-carbon bond; (3) stereoinversion of a C=N double bond to avoid the steric 
repulsion between substituents R3 and R4, and intramolecular nucleophilic cyclization; 
and (4) reductive elimination and elimination of methanol to give 
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1,3-diiminoisoindoline 3 and regenerate the rhenium catalyst. As described above, the 
stereochemistry of product 3 was determined by nuclear Overhauser effect 
experiments. In addition, the formation of methanol was detected by 1H NMR of the 
crude mixture. 
 
 
 
The imidate 1a was employed to conduct a gram-scale reaction, demonstrating 
the practicability of this method (Scheme 2.14). An annulation reaction of 1.09 g of 
aromatic imidate 1a with carbodiimide 2a gave 1.28 g of the desired product 3a in 85% 
yield. 
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A double annulation reaction also proceeded in excellent yield (Scheme 2.15). 
Treatment of aromatic diimidate 4 with N,N-diisopropylcarbodiimide (2a) in the 
presence of Re2(CO)10 catalyst in chlorobenzene at 170 °C for 24 h gave 
1,3-diiminoisoindoline 5 in 97% yield as a single product. The reaction proceeded 
highly regioselectively and only single product 5 was obtained, whereas a regioisomer 
could be formed. 
 
 
 
2.5 Summary 
I established a novel, facile and efficient method for the synthesis of 
1,3-diiminoisoindolines and their related compounds from aromatic or heteroaromatic 
imidates and carbodiimides via C-H bond activation. The desired reaction proceeded 
in advance of the consumption of carbodiimides by the addition of methanol 
(byproduct) to carbodiimides. To the best of my knowledge, this is the first example 
of a transition metal-catalyzed C-H insertion of carbodiimides. 
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Chapter 3 Iron-Catalyzed Acyloxyalkylation of Styrenes via 
Decarboxylation of Hypervalent Iodine(III) Reagents 
 
3.1 Introduction 
Organic reactions involving olefins play a very important role in the 
development of organic synthesis. Olefin compounds are readily available at low cost 
and allow for more conversion of functional groups. Therefore, it is necessary to 
develop new and efficient ways to realize olefin functionalization. Recently, transition 
metal-catalyzed difunctionalizations of alkenes are important topic because these 
reactions can synthesize highly functionalized backbones of pharmaceuticals and 
natural products.[1-4] In traditional oxyalkylation of alkenes, the osmium-catalyzed 
Sharpless epoxidation play an important role, but the toxic osmium catalyst and two 
steps (epoxidation and alkylation) are necessary, which hasn’t meet the requirements 
of modern organic reactions. Oxyalkylation of alkenes is still challenging and the 
examples are quite rare. 
 
3.2 Precedents of Metal-Catalyzed Oxyalkylation of Alkenes 
As a representative method for oxyalkylation of alkenes, epoxidation of alkenes 
is well known. However, the reaction requires two steps, epoxidation and alkylation, 
which is not ideal considering the requirements of modern organic reactions, such as 
environmentally benign, eased handling, low cost, and ready availability. Along this 
line, transition metal-catalyzed oxyalkylation of alkenes has received gradual 
attention. 
Ishii described a novel cobalt/N-hydroxyphthalimide co-catalytic method for a 
free radical addition of cycloalkanes and molecular oxygen to electron-deficient 
alkenes (Scheme 2.1).[5] A reaction between 1,3-dimethyladamantane and methyl 
acrylate under oxygen atmosphere in the presence of catalytic amounts of NHPI and 
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Co(acac)3 at 75 °C for 16 h gave oxyalkylated product in 91% yield.  
 
 
 
Zhang reported Cu-catalyzed difunctionalization of vinylarenes with cyclic 
ethers and oxygen in the presence of 1-1.2 equivalents of TBHP under aerobic 
conditions (Scheme 2.2).[6] The various oxyalkylated products of vinylarenes were 
obtained with excellent regioselectivity and good functional group tolerance. 
 
 
 
A similar result of regioselective oxyalkylation of vinylarenes catalyzed by 
diatomite supported manganese oxide nanoparticles was developed by Wang (Scheme 
2.3).[7] α-Carbonyl β-alkylated aryl derivatives can be obtained in good yields with 
high regioselectivity at 80 °C for 12 h under air atmosphere using a new 
heterogeneous catalyst SMONP-1. 
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A simple, practical, inexpensive and new strategy for synthesis of 
N-(3-oxo-3-phenylpropyl)-acetamide derivatives via a copper-catalyzed oxidative 
coupling between styrenes and N,N-disubstituted amides was reported by Mao 
(Scheme 2.4).[8] The reaction of various styrenes with N,N-disubstituted acetamides 
give the corresponding products in moderate yields. Furthermore, some amides 
products could be changed into β-amino carbonyls by successive hydrolysis. 
 
 
 
Zhu achieved copper-catalyzed intramolecular oxyalkylation of alkenes with 
alkylnitriles (Scheme 2.5).[9] Formation of C(sp3)-C(sp3) and C(sp3)-O bonds can be 
achieved from alkylnitriles by using copper salt in situ generated the alkylative 
lactonization products to generate two quaternary carbon atoms simultaneously. The 
addition of a cyanomethyl radical was not dependent on di-tert-butylperoxide (DTBP), 
which initiated the present domino process. 
 
 
 
Buchwald recently realized a rapid synthesis of enantiomerically enriched 
lactones by copper-catalyzed enantioselective radical oxyalkylation of alkenes 
(Scheme 2.6).[10] Enantioselective difunctionalization reactions including 
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oxyazidation, oxysulfonylation, oxyarylation, diacyloxylation, and oxyalkylation are 
applicable to the synthesis of various useful chiral lactones, which contains a 
tetrasubstituted stereocenter. 
 
 
 
Wang reported the first example which both of oxygenation and alkylation 
sources come from hypervalent iodine(III) reagents in the difunctionalizations of 
alkenes (Scheme 2.7).[11] This reaction proceeded via decarboxylative 
acyloxyalkylation of alkenes in the presence of a rhenium catalyst and hypervalent 
iodine(III) reagents. Visible light irradiation is, however, necessary to promote the 
reaction in some cases.  
 
 
 
3.3 Research Purpose 
Second and third row transition metal catalysts, such as rhenium, palladium, and 
gold exhibit powerful catalytic activities. However, the relatively high price and 
considerable toxicity limit their applications and improvements. Iron is the most 
abundant transition metal and has recently received much attention in synthetic 
organic chemistry.[12] 
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I successfully replaced the rhenium catalyst in the reaction (Scheme 2.7) with an 
iron catalyst. Iron-catalyzed acyloxyalkylation is economical and environmentally 
benign, and the reaction requires no visible light irradiation. 
I chose 1-(tert-butyl)-4-vinylbenzene (1a) and iodobenzene diacetate (2a) as 
model substrates for optimizing the reaction conditions (Table 3.1). Formation of the 
desired product was not observed in the presence of catalytic amounts of Fe(CO)3(cot) 
and phenanthroline (L1) (entry 1). Acyloxyalkylated product 3aa was obtained 
employing ligand L2 or L3 (entries 2 and 3). The desired product 3aa was not formed 
when electron-withdrawing or electron-donating groups were introduced into the 
phenyl groups of phenanthroline derivatives (entries 4 and 5). The results of 
phenanthrolines L6-L9 with substituents, Ph, tBu, nBu or Me groups, at the 2- and 
9-positions suggest that the two methyl groups on 2,9-position of phenanthroline are 
indispensable (entries 6-9). A combination of 4,7-diphenylphenanthroline and 
2,9-dimethylphenanthroline, 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline 
(bathocuproine, L10) gave the best result and 3aa was isolated in 53% yield (entry 
10). 9,10-Phenanthrenedione (L11) or 4,7-di(tert-butyl)bipyridine (L12) did not 
provide the desired product 3aa (entries 11 and 12). Acyloxyalkylated product 3aa 
was also delivered in 50% yield using Fe(OAc)2 as a catalyst (entry 13). Other iron 
complexes and salts gave 3aa the lower yields.[13] 
 
Figure 3.1 Elemental abundance 
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Next, the substrate scope of styrenes was investigated (Table 3.2). Styrenes 
bearing a methoxy group ,1b, or phenyl group, 1c, gave target products 3ba and 3ca 
without loss of the functional groups. α-Methylstyrenes 1d-1k bearing a strong 
electron-donating group, ester, halogens including iodine or naphthalenyl group, also 
reacted smoothly with iodobenzene diacetate. Styrenes 1l-1p with other α-substituent, 
such as benzyl, butyl, phenyl, or a substituted aromatic group, delivered the 
acyloxyalkylated products in moderate yields. The corresponding. five-membered 
heteroaromatic compounds with a vinyl group, 1q and 1r, were well compatible with 
the reaction conditions to form the corresponding acetoxyalkylated products 3qa and 
3ra in 66% and 51% yields, respectively. 
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Next, several hypervalent iodine(III) reagents were investigated as shown (Table 
3.3). In all entries, no visible light irradiation was necessary to produce radical species 
derived from the hypervalent iodine(III) reagents. Hypervalent iodine(III) reagents 
2b-2d attached primary, secondary, and tertiary aliphatic carboxylate provided the 
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desired acyloxyalkylated products 3bb-3bd in 63%-82% yields. In a previous study 
by Wang, no results of the using any hypervalent iodine(III) reagents containing 
functional groups were reported (Scheme 2.7).[11] I therefore screened hypervalent 
iodine(III) reagents 2e-2j bearing functional groups, such as trifluoromethyl, chlorine, 
bromine, or iodine atoms, carbonyl groups and inactive alkene moieties. As a result, 
the acyloxyalkylation reactions took place to give products 3be-3bj in moderate to 
good yields. The reaction of styrene 1b with hypervalent iodine(III) reagent 2k or 2l 
bearing 4-chlorophenyl or 4-methylbenzyl groups afforded the corresponding 
products in 73% and 52% yields, respectively. 
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To elucidate the reaction mechanism, we carried out a reaction in the presence of 
1.0 equivalent of 2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPO) as a radical 
scavenger under the standard reaction conditions to check whether the reation involve 
redical species or not. As a result, the acyloxyalkylation reaction was inhibited 
completely. This result indicated that the mechanism of the acyloxyalkylation reaction 
processes a radical pathway. The plausible reaction mechanism for the iron-catalyzed 
acyloxyalkylation of styrene derivatives using hypervalent iodine(III) reagents is 
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shown in Scheme 2.8, based on the previous report:[14] (1) Generation of cationic 
specie A through heterolysis of iodobenzene diacetate; (2) oxidation of A by Fen to 
give radical iodine intermediate B; (3) homolysis of B to provide radical species C 
with the formation of iodobenzene and release carbon dioxide; (4) addition of C 
radical to styrene derivative 1 to convey benzylic radical D; (5) oxidation of D by 
[Fe]n+1 to deliver benzylic cation E; and (6) nucleophilic attack of the carboxylate to 
E to give the desired product 3. 
 
 
 
For demonstrating the practicability of this method, gram scale reaction was 
conducted by treatment of 1.71 g of 1a with 2a in the presence of catalytic amounts of 
Fe(CO)3(cot) and L4 gave 1.15 g of 3aa in 46% yield (Scheme 2.9). 
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3.4 Summary 
I succeeded in the development of an iron-catalyzed acyloxyalkylation of styrene 
derivatives using hypervalent iodine(III) reagents. A variety of styrenes and 
hypervalent iodine(III) reagents were well compatible with the reaction conditions to 
give acyloxyalkylated products in moderate to good yields, even in gram scale, 
without loss of the functional groups. The phenanthroline ligands are very important 
in the reaction system even though the role of phenanthroline ligands is unclear. In a 
similar previously reported rhenium-catalyzed oxyalkylation, some cases needed 
visible light irradiation to promote reaction. The present reaction, however, required 
no irradiation. Furthermore, compared with Wang’s result, I expanded the scope of 
hypervalent iodine(III) reagents with functional. 
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Chapter 4 Summary 
 
I developed a rhenium-catalyzed synthesis of 1,3-diiminoisoindolines from 
aromatic imidates and carbodiimides via C-H bond activation (Scheme 4.1). Various 
unsymmetrical 1,3-diiminoisoindolines were obtained in good to excellent yields with 
good functional group tolerance. This reaction could be applicable for the gram-scale 
synthesis. To the best of my knowledge, this is the first example of a transition 
metal-catalyzed C-H insertion of carbodiimides, and this reaction is a novel method 
for synthesizing 1,3-diiminoisoindolines. Especially, it can be applied to synthesis of 
unsymmetrical 1,3-diiminoisoindolines. 
 
 
 
I also succeeded in the development of iron-catalyzed oxyalkylation of styrene 
derivatives using hypervalent iodine(III) reagents (Scheme 4.2). The choice of 
bathocuproine ligand was important to promote the reaction. Visible light irradiation 
was not necessary in this reaction. The reaction proceeded in moderate to good yields, 
even on gram scale, using a variety of styrenes and hypervalent iodine(III) reagents 
without loss of the functional groups. Compared with a previously reported similar 
rhenium-catalyzed oxyalkylation, the scope of hypervalent iodine(III) reagents with 
functional groups was expanded, and the iron-catalyzed reaction is expected to be 
used for the synthesis of medicines and nature products. 
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The following is a summary of the above: I have achieved to develop transition 
metal-catalyzed regioselective hydroarylation and acyloxyalkylation of unsaturated 
molecules. Both of reactions proceeded in good yields with high regioselectivity even 
in gram scale under low catalyst loadings. I hope that these results will give a useful 
insight into synthetic organic chemistry. 
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Experimental Section 
 
Rhenium-Catalyzed Synthesis of 1,3-Diiminoisoindolines via 
Insertion of Carbodiimides into a C-H Bond of Aromatic and 
Heteroaromatic Imidates 
 
General.  All reactions were carried out in a dry solvent under an argon atmosphere.  
Chlorobenzene was purchased from Aldrich Co. and were dried and degassed before 
use. Re2(CO)10 was purchased from Aldrich Co. Aromatic imidates (1a-1k and 4) and 
carbodiimides (2c-2h) were prepared according to the literature methods.1,2 
Carbodiimides (2a, 2b, and 2h) were purchased from Tokyo Kasei Kogyo Co. NMR 
spectra were recorded on JEOL ECX500 (500 MHz for 1H NMR and 125 MHz for 
13C NMR) and JEOL ECS400 (400 MHz for 1H NMR, 125 MHz for 13C NMR, 78 
MHz for 29Si, 376 MHz for 19F NMR) spectrometers. Proton chemical shifts are 
reported relative to Me4Si (CDCl3) at  0.00 ppm or residual solvent peak (CDCl3 at 
 7.26 ppm). Carbon chemical shifts are reported relative to CDCl3 at  77.26 ppm. 
Fluorine chemical shifts are reported relative to TFA (CDCl3) at  -76.55 ppm as an 
external standard. Infrared (IR) spectra were recorded on a JASCO FT/IR 410 Fourier 
transform infrared spectrophotometer. ESI-mass spectra were measured on a JEOL 
JMS-T100LC AccuTOF spectrometer for HRMS.  
 
Typical procedure for the preparation of (Z)-methyl N-octylbenzimidate (1a). A 
mixture of N-octylbenzamide (9.32 g, 40.0 mmol) and SOCl2 (40 mL) was refluxed 
for 24 h in a 100 mL round-bottom flask under an argon atmosphere. Then, the 
remained SOCl2 was removed in vacuo to give N-octylbenzimidoyl chloride. 
   To a 100 mL round-bottom flask was added MeONa (60.0 mmol in 5M Methanol 
solution) and remove MeOH by vacuum pump. Then, THF (40 mL) and the prepared 
(Z)-N-octylbenzimidoyl chloride in THF (20 mL) was added to the mixture and stirred 
at room temperature for 24 h. The resulting mixture was quenched with water and 
extracted with ethyl acetate (3 x 20 mL). And the combined organic layer was dried 
with anhydrous Na2SO4 and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (hexane/ethyl acetate = 19/1) to give (Z)-methyl 
N-octylbenzimidate as a yellow oil (1a, 7.71 g, 78% yield). 
 
Typical procedure for the preparation of 
N,N'-Methanediylidenebis(1-octanamine) (2c). A dry 100 mL round-bottom flask 
was charged with 80 mL of dichloromethane, 4.23 g of triphenylphosphine (16.1 
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mmol, 1.25 equiv), and a magnetic stir bar. A dry pressure-equalizing dropping funnel 
was charged with 6 mL of dichloromethane and 0.83 mL of bromine (16.1 mmol, 1.25 
equiv) and was then placed on the 100 mL round-bottom flask. The whole apparatus 
was placed under a nitrogen atmosphere, and the triphenylphosphine solution was 
cooled to 0 °C. The bromine solution was added dropwise over the course of 30 min, 
and the resulting solution was allowed to stir for an additional 10 min. To the resulting 
suspension of dibromotriphenylphosphorane, 4.5 mL of triethylamine (32.3 mmol, 
2.26 equiv) was added. In a similar fashion, 3.67 g of N,N′-di-n-octylurea (12.9 mmol) 
was added in five equivalent portions to the suspension at 0 °C over 1 h. One hour 
after the last addition of the urea, the reaction mixture was stirred at room temperature 
for overnight. Water was poured to the round-bottom flask in order to extract the 
triethylammonium hydrobromide, and organic and aqueous phases were separated 
using a separatory funnel. The organic phases were combined and dried over 
anhydrous Na2SO4. After the removal of solvent under reduced pressure, the crude 
product was purified by short column chromatography on silica gel with hexane as the 
eluent to give the pure product 2c as a colorless oil. Yield: 2.75g (80%) 
 
(Z)-Methyl N-octylbenzimidate (1a). 7.71 g, 78%; Yellow oil; 1H 
NMR (500 MHz, CDCl3) δ 7.33-7.24 (m, 3H), 7.24-7.17 (m, 2H), 
3.69 (s, 3H), 3.17 (t, J = 6.9 Hz, 2H), 1.45 (tt, J = 7.4, 6.9 Hz, 2H), 
1.25-1.01 (m, 10H), 0.77 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 160.7, 132.7, 129.3, 128.3, 128.0, 52.9, 50.1, 32.2, 32.0, 
29.5, 29.4, 27.4, 22.8, 14.2.; IR (neat, / cm-1) 2926, 2855, 1728, 1674, 1275, 1115, 
699; HRMS (ESI+) Calcd for C16H26NO [M+H]
+ 248.2014, Found 248.2025. 
 
(Z)-Methyl N-phenylbenzimidate (1b). 6.92 g, 91%; Yellow oil; 1H 
NMR (500 MHz, CDCl3) δ 7.33-7.27 (m, 3H), 7.22 (dd, J = 7.4, 7.4 
Hz, 2H), 7.17 (dd, J = 8.0, 8.0 Hz, 2H), 6.96 (t, J = 7.5 Hz, 1H), 6.73 
(d, J = 7.4 Hz, 2H), 3.98 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
159.3, 148.6, 131.5, 130.1, 129.5, 129.1, 128.1, 122.8, 121.9, 54.2. The analytical data 
match those reported in the literature.[3] 
 
(Z)-Methyl 4-methoxy-N-octylbenzimidate (1c). 3.24 g, 
62%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.30 (d, J = 
8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 3.81 (s, 3H), 3.77 (s, 
3H), 3.29 (t, J = 7.1 Hz, 2H), 1.54-1.48 (m, 2H), 1.51-1.21 (m, 
10H), 0.87 (t, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
160.5, 160.4, 129.8, 125.0, 113.7, 55.4, 53.0, 50.3, 32.3, 32.1, 29.6, 29.5, 27.4, 22.9, 
14.3.; IR (neat, / cm-1) 2927, 2854, 1670, 1609, 1511, 133, 1273, 1249, 1175, 836; 
HRMS (ESI+) Calcd for C17H28NO2 [M+H]
+ 278.2120, Found 278.2122 
 
(Z)-Methyl N-octyl-4-(trifluoromethyl)benzimidate (1d). 5.45 g, 80%; Yellow oil; 
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1H NMR (500 MHz, CDCl3) δ 7.68 (d, J = 8.1 Hz, 2H), 7.44 (d, 
J = 8.1 Hz, 2H), 3.80 (s, 3H), 3.22 (t, J = 7.1 Hz, 2H), 
1.57-1.46 (m, 2H), 1.37-1.14 (m, 10H), 0.87 (t, J = 6.9 Hz, 3H); 
13C NMR (125 MHz, CDCl3) δ 159.4, 136.3, 131.5 (q, 2JCF = 
37.4 Hz), 128.6, 125.5 (q, 3JCF = 3.8 Hz), 124.1 (q, 
1JCF = 271 
Hz), 53.3, 50.2, 32.13, 32.08, 29.6, 29.5, 27.4, 22.9, 14.3; IR (neat, / cm-1) 2928, 
2856, 1676, 1620, 1326, 846; HRMS (ESI+) Calcd for C17H25F3NO [M+H]
+ 316.1888, 
Found 316.1877. 
 
(Z)-Methyl 4-(methoxy(octylimino)methyl)benzoate (1e). 
3.55 g, 50%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 8.07 
(d, J = 8.2 Hz, 2H), 7.39 (d, J = 8.2 Hz, 2H), 3.92 (s, 3H), 
3.79 (s, 3H), 3.21 (t, J = 7.1 Hz, 2H), 1.57-1.42 (m, 2H), 
1.42-1.12 (m, 10H), 0.85 (t, J = 6.9 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 166.7, 159.87, 137.047, 131.0, 129.8, 128.2, 53.2, 52.5, 50.1, 32.1, 
32.0, 29.6, 29.5, 27.4, 22.9, 14.3; IR (neat, / cm-1) 2927, 2855, 1730, 1672, 1435, 
1277, 1117, 1020, 714; HRMS (ESI+) Calcd for C18H28NO3 [M+H]
+ 306.2069, Found 
306.2057. 
 
(Z)-Methyl 4-bromo-N-octylbenzimidate (1f). 4.40 g, 78%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 8.4 Hz, 
2H), 7.20 (d, J = 8.4 Hz, 2H), 3.77 (s, 3H), 3.23 (t, J = 7.1 Hz, 
2H), 1.55-1.47 (m, 2H), 1.30-1.15 (m, 10H), 0.87 (t, J = 6.9 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 159.7, 131.7, 131.5, 129.8, 
123.8, 53.2, 50.2, 32.2, 32.1, 29.6, 29.5, 27.4, 22.9, 14.3; IR (neat, / cm-1) 2926, 
2854, 1671, 1282, 1282, 1013, 829, 667; HRMS (ESI+) Calcd for C16H25BrNO 
[M+H]+ 326.1120, Found 326.1128. 
 
(Z)-Methyl N-octyl-[1,1'-biphenyl]-4-carbimidate (1g). 6.44 
g,  66%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.70-7.58 
(m, 4H), 7.52-7.42 (m, 4H), 7.39 (t, J = 7.3 Hz, 1H), 3.85 (s, 
3H), 3.36 (t, J = 7.1 Hz, 2H), 1.66-1.52 (m, 2H), 1.43-1.18 (m, 
10H), 0.90 (t, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
160.6, 142.3, 140.6, 131.6, 129.1, 128.6, 127.9, 127.4, 127.2, 53.1, 50.3, 32.3, 32.1, 
29.6, 29.5, 27.5, 22.9, 14.3; IR (neat, / cm-1) 2926, 2854, 1668, 1277, 1113, 768, 738, 
697; HRMS (ESI+) Calcd for C22H30NO [M+H]
+ 324.2327, Found 324.2325. 
 
(Z)-Methyl 3-methyl-N-octylbenzimidate (1h). 4.52 g, 65%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.25 (dd, J = 7.5, 7.3 Hz, 
1H), 7.18 (d, J = 7.5 Hz, 1H), 7.13-7.06 (m, 2H), 3.76 (s, 3H), 3.22 
(t, J = 7.1 Hz, 2H), 2.35 (s, 3H), 1.57-1.43 (m, 2H), 1.32-1.13 (m, 
10H), 0.84 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 161.2, 
138.3, 132.8, 130.2, 128.6, 128.3, 125.1, 53.1, 50.2, 32.2, 32.1, 29.6, 
29.5, 27.4, 22.9, 21.6, 14.4; IR (neat, / cm-1) 2926, 2855, 1730, 1671, 1639, 1278, 
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1116, 713; HRMS (ESI+) Calcd for C17H28NO [M+H]
+ 262.2171, Found 262.2166. 
 
(Z)-Methyl N-octyl-1-naphthimidate (1i). 5.28 g, 67%; 
Reddish brown oil; 1H NMR (500 MHz, CDCl3) δ 7.91-7.84 (m, 
2H), 7.72-7.68 (m, 1H), 7.50-7.46 (m, 3H), 7.35 (d, J = 6.9, 
1H), 3.93 (s, 3H), 3.03 (t, J = 7.1 Hz, 2H), 1.51-1.46 (m, 2H), 
1.30-1.09 (m, 10H), 0.85 (t, J = 7.1 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 161.2, 133.6, 131.8, 130.3, 129.4, 128.6, 127.0, 126.5, 125.6, 125.5, 
125.3, 53.3, 50.3, 32.1, 31.9, 29.6, 29.5, 27.4, 22.9, 14.3; IR (neat, / cm-1) 3058, 
2927, 2854, 1672, 1458, 1284, 1105, 820, 750; HRMS (ESI+) Calcd for C20H28NO 
[M+H]+ 298.2171, Found 298.2166. 
 
(Z)-Methyl N-octylfuran-3-carbimidate (1j). 4.38 g, 67%; Yellow 
oil; 1H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 1.1 Hz, 1H), 7.43 (dd, 
J = 2.0, 1.5 Hz, 1H), 6.65-6.58 (m, 1H), 3.73 (s, 3H), 3.40 (t, J = 7.1 
Hz, 2H), 1.65-1.57 (m, 2H), 1.40-1.25 (m, 10H), 0.88 (t, J = 6.9 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 154.1, 143.9, 142.8, 117.5, 
110.4, 52.7, 50.0, 32.3, 32.1, 29.7, 29.6, 27.6, 22.9, 14.4; IR (neat, / cm-1) 2927, 
2854, 1671, 1296, 1162; HRMS (ESI+) Calcd for C14H24NO2 [M+H]
+ 238.1807, 
Found 238.1801. 
 
(Z)-Methyl N-octylthiophene-3-carbimidate (1k). 5.48 g, 60%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.43 (dd, J = 2.9, 1.1 Hz, 
1H), 7.24 (dd, J = 5.0, 2.9 Hz, 1H), 7.13 (dd, J = 5.0, 1.1 Hz, 1H), 
3.68 (s, 3H), 3.31 (t, J = 7.1 Hz, 2H), 1.50-1.45 (m, 2H), 1.30-1.10 
(m, 10H), 0.80 (t, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
155.8, 132.7, 127.7, 127.0, 125.4, 52.9, 50.2, 32.3, 32.1, 29.7, 29.5, 27.5, 22.9, 14.3; 
IR (neat, / cm-1) 2926, 2854, 1671, 1264, 1198, 795, 705; HRMS (ESI+) Calcd for 
C14H24NOS [M+H]
+ 254.1579, Found 254.1577. 
 
N,N'-Methanediylidenebis(1-octanamine) (2c). 5.03 g, 
80%; Colorless oil; 1H NMR (500 MHz, CDCl3) δ 3.16 (t, 
J = 6.8 Hz, 4H), 1.57-1.50 (m, 4H), 1.35-1.23 (m, 20H), 0.86 (t, J = 6.5 Hz, 6H); 13C 
NMR (125 MHz, CDCl3) δ 140.7, 47.0, 32.0, 31.5, 29.44, 29.39, 27.1, 22.9, 14.3; 
HRMS (ESI+) Calcd for C17H35N2 [M+H]
+ 267.2800, Found 267.2789 
 
N,N'-Methanediylidenebis(2-(4-chlor
ophenyl)ethanamine) (2d). 2.24 g, 
62%; Yellow solid; 1H NMR (500 
MHz, CDCl3) δ 7.20 (d, J = 8.2 Hz, 
4H), 7.03 (d, J = 8.2 Hz, 4H), 3.22 (t, J = 7.0 Hz, 4H), 2.64 (t, J = 7.0 Hz, 4H); 13C 
NMR (125 MHz, CDCl3) δ 140.1, 137.5, 132.5, 130.4, 128.8, 47.7, 36.9; IR (KBr, / 
cm-1) 3329, 2932, 2126, 1638, 1492, 1342, 1015, 812; HRMS (ESI+) Calcd for 
C17H16Cl2N2Na [M+Na]
+ 341.0588, Found 341.0594. 
 49 
 
N,N'-Methanediylidenebis(3-(triethoxys
ilyl)propan-1-amine) (2e). 3.73 g, 80%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 
3.84-3.67 (m, 12H), 3.22-3.10 (m, 4H), 
1.73-1.55 (m, 4H), 1.24-1.10 (m, 18H), 
0.67-0.56 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 140.5, 58.5, 49.5, 25.1, 18.4, 7.9; 
IR (neat, / cm-1) 2973, 2927, 2129, 1637, 1369, 1080, 956, 793; HRMS (ESI+) Calcd 
for C19H42N2O6Si2Na [M+Na]
+ 473.2479, Found 473.2501. 
 
N,N'-Methanediylidenebis(1-phenylmethanamine) (2f). 1.29 
g, 44%; Yellow solid;  1H NMR (500 MHz, CDCl3) δ 
7.35-7.26 (m, 6H), 7.20 (d, J = 7.1 Hz, 4H), 4.30 (s, 4H); 13C 
NMR (125 MHz, CDCl3) δ 141.6, 138.5 128.7, 127.7, 127.6, 50.5; IR (KBr, / cm-1) 
1685, 1654, 1559, 1457, 1026, 696; HRMS (ESI+) Calcd for C15H14N2Na [M+Na]
+ 
245.1055, Found 245.1052. 
 
Bis(1-phenylethyl)methanediimine (2g). 2.23g, 38%; Yellow 
oil; 1H NMR (500 MHz, CDCl3) δ 7.36-7.29 (m, 5H), 
7.29-7.23 (m, 5H), 4.62-4.52 (m, 2H), 1.50-1.44 (m, 6H);13C 
NMR (125 MHz, CDCl3) δ 143.8, 128.7, 127.53, 127.51, 126.2, 56.9, 24.9; IR (neat, 
/ cm-1) 2973, 2124, 1684, 1453, 1072, 759, 699; HRMS (ESI+) Calcd for C17H19N2 
[M+H]+ 251.1548, Found 251.1548. 
 
N,N'-Methanediylidenebis(4-(trifluoromet
hyl)aniline) (2i). 1.47 g, 70%; Reddish 
brown oil; 1H NMR (500 MHz, CDCl3) δ 
7.61 (d, J = 7.8 Hz, 4H), 7.27 (d, J = 7.8 Hz, 4H), 13C NMR (125 MHz, CDCl3) δ 
141.4, 133.6, 129.3 (q, 1JCF = 273 Hz), 127.1 (q, 
3JCF = 4.0 Hz), 124.8 (q, 
2JCF = 30.1 
Hz), 123.1; IR (KBr, / cm-1) 2163, 1664, 1468, 928, 893, 703, HRMS (ESI+) Calcd 
for C15H9F6N3 [M+H]
+ 331.0670, Found 331.0672. 
 
Typical procedure for rhenium-catalyzed synthesis of 
(E)-N-((E)-2-Isopropyl-3-(isopropylimino)-1-isoindolinylidene)-1-octanamine 3a 
by a C-H bond activation and successive dealkoxylative annulation. A mixture of 
(Z)-methyl N-octylbenzimidate (1a, 61.8 mg, 0.250 mmol), 
N,N'-methanediylidenebis(propan-2-amine) (2a, 31.5 mg, 0.250 mmol), Re2(CO)10 
(4.1 mg, 6.3 mol), and chlorobenzene (1.0 mL) was stirred at 170 °C for 24 h in a 
sealed tube. Then, the solvent was removed in vacuo and the product was isolated by 
column chromatography on silica gel (n-hexane/EtOAc = 10:1) to give 
(E)-N-((E)-2-isopropyl-3-(isopropylimino)-1-isoindolinylidene)-1-octanamine (3a, 
84.8 mg, 99% yield). 
 
(E)-N-((E)-2-Isopropyl-3-(isopropylimino)-1-isoindolinylidene)-1-octanamine 
(3a). 84.8 mg, 99%; Yellow oil;  1H NMR (500 MHz, CDCl3) δ 8.02-7.94 (m, 2H), 
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7.50-7.39 (m, 2H), 4.89 (hept, J = 5.7 Hz, 1H), 4.54 (hept, J = 5.7 Hz, 
1H), 3.87 (t, J = 6.9 Hz, 2H), 1.78-1.69 (m, 2H), 1.46 (m, 8H), 
1.38-1.20 (m, 14H), 0.86 (t, J = 6.7 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 151.1, 149.3, 131.9, 131.4, 130.3, 130.1, 126.2, 126.1, 50.2, 
48.6, 43.1, 32.8, 32.1, 29.8, 29.6, 27.8, 25.3, 23.0, 19.6, 14.4; IR 
(neat, / cm-1) 2963, 2926, 2855, 1637, 1362, 1239, 1096, 767, 674; HRMS (ESI+) 
Calcd for C22H36N3 [M+H]
+ 342.2909, Found 342.2899. 
 
(E)-N-((E)-5-Bromo-2-isopropyl-3-(isopropylimino)isoindolin
-1-ylidene) -1-propanamine (3A). 71.8 mg, 82%; Yellow oil; 1H 
NMR (400 MHz, CDCl3) δ 8.11 (s, 1H), 7.87 (d, J = 8.2 Hz, 1H), 
7.62 (d, J = 8.2 Hz, 1H), 4.89 (hept, J = 7.5 Hz, 1H), 4.48 (hept, 
J = 7.1 Hz, 1H), 3.81 (t, J = 6.7 Hz, 2H), 1.83-1.69 (m, 2H), 1.45 
(d, J = 7.5 Hz, 6H), 1.30 (d, J = 7.1 Hz, 6H), 1.05 (t, J = 7.2 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 150.3, 147.9, 133.0, 130.6, 
130.0, 129.2, 127.4, 124.6, 52.0, 48.7, 43.3, 26.0, 25.3, 19.5, 12.3; IR (KBr, / cm-1) 
2966, 2929, 1634, 1376, 1313, 806; HRMS (ESI+) Calcd for C17H25BrN3 [M+H]
+ 
350.1232, Found 350.1241. 
 
nOe correlation of 3A 
 
 
(E)-N-((E)-2-Isopropyl-3-(isopropylimino)-1-isoindolinylidene)an
iline (3b). 65.4 mg, 85%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 
7.94 (d, J = 7.9 Hz, 1H), 7.40 (dd, J = 7.6, 7.6 Hz, 1H), 7.36-7.29 (m, 
2H), 7.14-7.10 (m, 2H), 6.93 (d, J = 8.0 Hz, 2H), 6.68 (d, J = 7.7 Hz, 
1H), 4.99 (hept, J = 6.9 Hz, 1H), 4.60 (hept, J = 6.1 Hz, 1H), 1.56 (d, 
J = 6.9 Hz, 6H), 1.33 (d, J = 6.1 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 150.6, 148.8, 
131.1, 131.0, 130.8, 130.5, 129.6, 129.2, 125.8, 125.6, 122.6, 120.6, 48.7, 43.5, 24.9, 
19.4; IR (neat, / cm-1) 3293, 2969, 1855, 1633, 1360, 1028, 774; HRMS (ESI+) 
Calcd for C20H24N3 [M+H]
+ 306.1970, Found 306.1984. 
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(E)-N-((E)-2-Isopropyl-3-(isopropylimino)-5-methoxy-1-isoi
ndolinylidene)-1-octanamine (3c). 89.3 mg, 99%; Yellow oil; 
1H NMR (500 MHz, CDCl3) δ 7.92 (d, J = 8.6 Hz, 1H), 7.50 (d, 
J = 2.4 Hz, 1H), 6.98 (dd, J = 8.6, 2.4 Hz, 1H), 4.88 (hept, J = 
7.5 Hz, 1H), 4.52 (hept, J = 6.3 Hz, 1H), 3.87 (s, 3H), 3.84 (t, J 
= 7.0 Hz, 2H), 1.81-1.69 (m, 2H), 1.52-1.41 (m, 8H), 1.41-1.22 (m, 14H), 0.91-0.86 
(m, 3H); 13C NMR (125 MHz, CDCl3) δ 161.1, 151.1, 149.1, 133.2, 127.3, 124.9, 
114.6, 112.5, 55.9, 50.2, 48.5, 43.1, 32.8, 32.1, 29.8, 29.6, 27.8, 25.1, 22.9, 19.6, 14.4; 
IR (neat, / cm-1) 2962, 2926, 2855, 1635, 1361, 1290, 1234, 1109; HRMS (ESI+) 
Calcd for C23H38N3O [M+H]
+ 372.3015, Found 372.3029. 
 
(E)-N-((E)-2-Isopropyl-3-(isopropylimino)-5-(trifluoromet
hyl)-1-isoindolinylidene)-1-octanamine (3d). 101 mg, 99%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 8.21 (s, 1H), 8.14 
(d, J = 8.1 Hz, 1H), 7.76 (d, J = 8.1 Hz, 1H), 5.93 (hept, J = 
7.4 Hz, 1H), 4.55 (hept, J = 6.3 Hz, 1H), 3.91 (t, J = 6.8 Hz, 
2H), 1.82-1.71 (m, 2H), 1.56-1.43 (m, 8H), 1.42-1.18 (m, 14H), 0.89 (t, J = 6.9 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 149.8, 147.8, 134.5, 132.2 (q, 2JCF = 33.1 Hz), 
131.7, 127.1 (q, 3JCF = 3.0 Hz), 126.5, 123.9 (q, 
1JCF = 272 Hz), 122.9 (q, 
3JCF = 3.8 
Hz), 50.3, 48.8, 43.4, 32.8, 32.1, 29.7, 29.6, 27.8, 25.3, 23.0, 19.5, 14.4; IR (neat, / 
cm-1) 1965, 2927, 2856, 1638, 1325, 1134, 839, 666; HRMS (ESI+) Calcd for 
C23H35F3N3 [M+H]
+ 410.2783, Found 410.2795. 
 
(1E,3E)-Methyl 
2-isopropyl-3-(isopropylimino)-1-(octylimino)isoindoline-
5-carboxylate (3e). 97.7 mg, 97%; Yellow oil; 1H NMR 
(500 MHz, CDCl3) δ 8.62 (s, 1H), 8.17 (d, J = 7.9 Hz, 1H), 
8.06 (d, J = 7.9 Hz, 1H), 4.92 (hept, J = 10.1Hz, 1H), 4.62 
(hept, J = 5.3 Hz, 1H), 3.97 (s, 3H), 3.90 (t, J = 6.4 Hz, 2H), 1.82-1.70 (m, 2H), 
1.49-1.43 (m, 8H), 1.41-1.21 (m, 14H), 0.88 (t, J = 5.7 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 166.4, 150.2, 148.2, 135.2, 131.7, 131.5, 131.4, 127.2, 126.0, 52.8, 50.4, 
48.7, 43.3, 32.8, 32.1, 29.7, 29.6, 27.8, 25.3, 22.9, 19.6, 14.4; IR (neat, / cm-1) 3398, 
2928, 1636, 1259, 1031; HRMS (ESI+) Calcd for C24H38N3O2 [M+H]
+ 400.2964, 
Found 400.2956.  
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(E)-N-((E)-5-Bromo-2-isopropyl-3-(isopropylimino)-1-isoindo
linylidene)-1-octanamine (3f). 101 mg, 96%; reddish brown 
solid; 1H NMR (500 MHz, CDCl3) δ 8.11 (s, 1H), 7.87 (d, J = 8.2 
Hz, 1H), 7.61 (d, J = 8.2 Hz, 1H), 4.89 (hept, J = 6.3 Hz, 1H), 
4.85 (hept, J = 5.7 Hz, 1H), 3.84 (t, J = 6.7 Hz, 2H), 1.80-1.68 
(m, 2H), 1.45-1.35 (m, 8H), 1.33-1.26 (m, 14H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 150.0, 147.7, 132.8, 132.7, 130.2, 129.0, 127.1, 124.4, 49.8, 48.7, 
43.2, 32.4, 31.9, 29.5, 29.4, 27.5, 25.0, 22.7, 19.2, 14.1; IR (KBr, / cm-1) 2929, 2832, 
1658, 1378, 1030, 717, 700; HRMS (ESI+) Calcd for C22H35BrN3 [M+H]
+ 420.2014, 
Found 420.2015. 
 
(E)-N-((E)-2-Isopropyl-3-(isopropylimino)-5-phenylisoindolin
-1-ylidene)octan-1-amine (3g). 104 mg, 99%; Yellow solid;1H 
NMR (500 MHz, CDCl3) δ  8.19 (s, 1H), 8.07 (d, J = 8.1 Hz, 
1H), 7.70 (d, J = 8.1 Hz, 1H), 7.64-7.58 (m, 2H), 7.50 (m, 2H), 
7.43 (t, J = 7.5 Hz, 1H), 4.92 (hept, J = 5.0 Hz, 1H), 4.65 (hept, J 
= 7.5 Hz, 1H), 3.93 (t, J = 6.9 Hz, 2H), 1.85-1.70 (m, 2H), 1.57-1.41 (m, 8H), 
1.44-1.18 (m, 14H), 0.90 (t, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 151.1, 
149.2, 143.5, 140.6, 132.2, 130.7, 129.3, 129.1, 128.3, 127.6, 126.5, 125.0, 50.3, 48.7, 
43.2, 32.8, 32.2, 29.8, 29.7, 27.8, 25.4, 23.0, 19.6, 14.4; IR (neat, / cm-1) 2963, 2926, 
1635, 1360; HRMS (ESI+) Calcd for C28H40N3 [M+H]
+ 418.3222, Found 418.3235. 
 
(E)-N-((E)-2-Isopropyl-3-(isopropylimino)-4-methyl-1-isoindolin
ylidene)-1-octanamine (3h). 25.2 mg, 28%; Yellow oil; 1H NMR 
(500 MHz, CDCl3) δ 7.75 (d, J = 7.6 Hz, 1H), 7.30 (dd, J = 7.6, 5.3 
Hz, 1H), 7.25 (d, J = 5.3 Hz, 2H), 4.56 (hept, J = 6.3 Hz, 1H), 4.30 
(hept, J = 6.3 Hz, 1H), 3.95-3.87 (m, 2H), 2.74 (s, 3H), 1.64-1.55 (m, 
2H), 1.39-1.15 (m, 22H), 0.88 (t, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
151.6, 146.9, 137.3, 134.9, 133.6, 129.6, 129.1, 122.7, 48.4, 47.4, 42.3, 32.1, 29.5, 
29.44, 29.43, 27.1, 26.1, 25.2, 22.9, 20.5, 14.4; IR (neat, / cm-1) 2964, 2925, 1636, 
1360; HRMS (ESI+) Calcd for C23H38N3 [M+H]
+ 356.3066, Found 356.3076. 
  
(E)-N-((E)-2-Isopropyl-3-(isopropylimino)-5-methylisoindolin-1-ylidene)octan-1-
amine (3h'). 65.1 mg, 70%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 
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8.0 Hz, 1H), 7.81 (s, 1H), 7.29 (d, J = 8.0 Hz, 1H), 4.89 (hept, J = 
7.5 Hz, 1H), 4.53 (hept, J = 6.0 Hz, 1H), 3.89 (t, J = 6.9 Hz, 2H), 
2.46 (s, 3H), 1.83-1.72 (m, 2H), 1.54-1.42 (m, 8H), 1.41-1.18 (m, 
14H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
151.3, 149.5, 140.4, 132.3, 131.0, 128.9, 126.9, 125.9, 50.2, 48.6, 
43.1, 32.8, 32.1, 29.9, 29.7, 27.8, 25.3, 23.0, 22.1, 19.6, 14.4; IR (neat, / cm-1) 2964, 
2925, 2856, 1635, 1362; HRMS (ESI+) Calcd for C23H38N3 [M+H]
+ 356.3066, Found 
356.3053. 
 
(E)-N-((E)-2-Isopropyl-3-(isopropylimino)-2,3-dihydro-1H-ben
zo[e]isoindol-1-ylidene)octan-1-amine (3i). 91.8 mg, 94%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 9.82 (d, J = 8.5 Hz, 1H), 
7.93 (d, J = 8.5 Hz, 1H), 7.89-7.79 (m, 2H), 7.60 (t, J = 7.5 Hz, 
1H), 7.54 (t, J =7.5 Hz, 1H), 4.78-4.62 (m, 2H), 3.88 (t, J = 6.7 Hz, 
2H), 1.89-1.75 (m, 2H), 1.60 (t, J = 8.3 Hz, 5H), 1.57-1.45 (m, 3H), 1.44-1.21 (m, 
14H), 0.89 (t, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3) 152.3, 151.8, 134.8, 
133.0, 131.1, 129.1, 128.4, 128.1, 128.0, 127.3, 127.2, 121.7, 50.6, 48.9, 48.3, 33.5, 
32.1, 29.8, 29.6, 27.8, 25.4, 23.0, 21.0, 14.4.; IR (neat, / cm-1) 2962, 2925, 2855, 
1638, 1360, 1238; HRMS (ESI+) Calcd for C26H38N3 [M+H]
+ 392.3066, Found 
392.3042. 
 
(E)-N-((E)-5-Isopropyl-6-(isopropylimino)-5,6-dihydro-4H-furo[2,
3-c]pyrrol-4-ylidene)octan-1-amine (3j). 52.3 mg, 63%; Yellow oil; 
1H NMR (500 MHz, CDCl3) δ 7.56 (d, J =1.3 Hz, 1H), 6.62 (d, J = 
1.3 Hz, 1H), 4.70 (hept, J = 6.9 Hz, 1H), 4.31 (hept, J = 6.3 Hz, 1H), 
3.62 (t, J = 7.1 Hz, 2H), 1.74-1.52 (m, 2H), 1.44 (d, J = 6.9 Hz, 6H), 
1.42-1.24 (m, 10H), 1.23 (d, J = 6.2 Hz, 6H), 0.87 (t, J = 6.6 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 154.2, 149.0, 148.4, 143.5, 122.4, 108.1, 52.1, 51.9, 44.0, 32.14, 
32.10, 29.8, 29.6, 27.7, 25.4, 22.9, 20.1, 14.4; IR (neat, / cm-1) 2963, 2927, 1651, 
1378, 1070; HRMS (ESI+) Calcd for C20H34N3O [M+H]
+ 332.2702, Found 332.2697. 
 
(E)-N-((E)-5-Isopropyl-6-(isopropylimino)-5,6-dihydro-4H-thieno[
2,3-c]-4-pyrrolylidene)-1-octanamine (3k). 59.0 mg, 68%; Yellow 
oil; 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 4.9 Hz, 1H), 7.35 (d, J 
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= 4.9 Hz, 1H), 4.79 (hept, J = 6.9 Hz, 1H), 3.91 (hept, J = 6.3 Hz, 1H), 3.73 (t, J = 7.1 
Hz, 2H), 1.73-1.64 (m, 2H), 1.49-1.38 (m, 8H), 1.32-1.24 (m, 14H), 0.88 (t, J = 6.9 
Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 150.3, 147.8, 138.9, 134.4, 132.9, 122.6, 
53.2, 51.1, 43.9, 32.3, 32.1, 29.8, 29.6, 27.8, 25.0, 22.9, 20.0, 14.4.; IR (neat, / cm-1) 
2964, 2926, 1637, 1378, 698; HRMS (ESI+) Calcd for C20H34N3S [M+H]
+ 348.2473, 
Found 348.2479. 
 
(E)-N-((E)-2-Cyclohexyl-3-(octylimino)isoindolin-1-ylidene)cyclo
hexanamine (3l). 95.0 mg, 90%; Yellow solid; 1H NMR (500 MHz, 
CDCl3) δ 8.00 (dd, J = 5.8, 2.7 Hz, 1H), 7.89 (dd, J = 5.8, 2.5 Hz, 
1H), 7.50-7.45 (m, 2H), 4.60-4.45 (m, 1H), 4.27-4.15 (m, 1H), 3.89 
(t, J = 6.9 Hz, 2H), 2.71-2.59 (m, 2H), 2.05-1.70 (m, 8H), 1.69-1.09 
(m, 22H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 151.3, 149.2, 131.8, 
131.3, 130.3, 130.0, 126.2, 126.0, 56.2, 51.5, 50.1, 35.2, 32.7, 32.1, 29.7, 29.7, 28.8, 
27.7, 26.9, 26.3, 26.2, 24.7, 23.0, 14.4; IR (KBr, / cm-1) 3361, 2920, 2849, 1651, 
1469, 1371, 1101, 771, 698, 673; HRMS (ESI+) Calcd for C28H44N3 [M+H]
+ 422.3535, 
Found 422.3518. 
 
(N,N'E,N,N'E)-N,N'-(2-Octylisoindoline-1,3-diylidene)bis(1-oc
tanamine) (3m). 114 mg, 94%; Yellow solid; 1H NMR (500 
MHz, CDCl3) δ 8.01 (dd, J = 5.7, 3.1 Hz, 2H), 7.53-7.50 (m, 2H), 
3.91 (t, J = 7.0 Hz, 4H), 3.80 (t, J = 7.0 Hz, 2H), 1.93-1.73 (m, 
4H), 1.53-1.43 (m, 4H), 1.35-1.27 (m, 28H), 0.93-0.84 (m, 9H); 
13C NMR (125 MHz, CDCl3) δ 151.4, 131.8, 130.3, 126.2, 50.0, 39.0, 32.6, 32.2, 32.1, 
29.8, 29.7, 29.66 (2C), 29.57, 27.9, 27.8, 27.3, 23.0 (2C), 14.4; IR (KBr, / cm-1) 2921, 
1635, 1397, 1100, 676; HRMS (ESI+) Calcd for C3H25N3 [M+H]
+ 482.4474, Found 
482.4491. 
 
(E)-N-((E)-2-(4-Chlorophenethyl)-3-((4-chlorophenet
hyl)imino)isoindolin-1-ylidene)octan-1-amine (3n). 
110 mg, 83%; Yellow solid; 1H NMR (500 MHz, CDCl3) 
δ 8.00 (d, J = 7.1 Hz, 1H), 7.95 (d, J = 7.0 Hz, 1H), 
7.56-7.47 (m, 2H), 7.33-7.24 (m, 4H), 7.24-7.18 (m, 
2H), 7.14 (d, J = 8.2 Hz, 2H), 4.12 (t, J = 7.0 Hz, 2H), 4.01 (t, J = 6.9 Hz, 2H), 3.88 (t, 
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J = 6.8 Hz, 2H), 3.03 (t, J = 7.0 Hz, 2H), 2.94 (t, J = 6.9 Hz, 2H), 1.81-1.68 (m, 2H), 
1.55-1.45 (m, 2H), 1.43-1.23 (m, 8H), 0.89 (t, J = 6.6 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 151.4, 150.8, 139.6, 138.9, 132.0, 131.8, 131.60, 131.56 (2C), 130.7, 130.6, 
130.5, 128.6, 128.4, 126.3, 126.1, 51.4, 50.0, 40.3, 38.6, 33.4, 32.6, 32.2, 29.8, 29.7, 
27.8, 23.0, 14.4; IR (KBr, / cm-1) 2923, 2850, 1644, 1490, 1428, 1396, 1338, 1093, 
1014, 820, 667; HRMS (ESI+) Calcd for C32H38Cl2N3 [M+H]
+ 534.2443, Found 
534.2446. 
 
(E)-N-((E)-2-(3-(Triethoxysilyl)propyl)-3-((3-(triethox
ysilyl)propyl)imino)isoindolin-1-ylidene)octan-1-amin
e (3o). 139 mg, 83%; Yellow oil; 1H NMR (500 MHz, 
CDCl3) δ 8.05-7.96 (m, 2H), 7.54-7.47 (m, 2H), 
3.95-3.73 (m, 16H), 1.92-1.80 (m, 2H), 1.79-1.67 (m, 6H), 
1.50-1.41 (m, 2H), 1.38-1.26 (m, 10H), 1.26-1.15 (m, 
16H), 0.91-0.78 (m, 5H), 0.66 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 151.4, 151.3, 
131.8, 131.7, 130.40, 130.37, 126.3, 126.2, 58.6, 58.5, 52.7, 50.7, 50.1, 41.7, 32.7, 
32.2, 29.8, 29.6, 27.8, 25.9, 25.8, 22.9, 21.1, 18.6, 18.5, 14.4; 29Si NMR (78 MHz, 
CDCl3) δ -44.3, -44.4; IR (KBr, / cm-1) 2128, 1647, 1079, 956, 792; HRMS (ESI+) 
Calcd for C34H64N3O6Si2 [M+H]
+ 666.4334, Found 666.4330. 
 
(E)-N-((E)-2-Benzyl-3-(benzylimino)isoindolin-1-ylidene)octan
-1-amine (3p). 69.0 mg, 63%; Yellow solid; 1H NMR (500 MHz, 
CDCl3) δ 8.05 (d, J = 6.9 Hz, 2H), 7.58-7.51 (m, 2H), 7.49 (d, J = 
7.3 Hz, 2H), 7.43 (d, J = 7.3 Hz, 2H), 7.36-7.31 (m, 2H), 
7.30-7.22 (m, 3H), 7.23-7.16 (m, 1H), 5.21 (s, 2H), 5.15 (s, 2H), 
3.95 (t, J = 6.9 Hz, 2H), 1.84-1.74 (m, 2H), 1.53-1.43 (m, 2H), 1.41-1.21 (m, 8H), 
0.90 (t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 152.3, 151.0, 141.8, 139.7, 
131.7 (2C), 130.8, 130.7, 128.9, 128.5, 128.2, 127.4, 126.7, 126.6, 126.4, 125.3, 53.3, 
50.0, 42.6, 32.6, 32.2, 29.8, 29.7, 27.7, 23.0, 14.4; IR (KBr, / cm-1) 2923, 1646, 1396, 
1100, 720, 694; HRMS (ESI+) Calcd for C30H36N3 [M+H]
+ 438.2909, Found 
438.2927. 
 
(E)-N-((E)-2-(1-Phenylethyl)-3-(1-phenylethyl)imino)isoindolin-1-ylidene)octan-1
-amine (dr = 2:1) (3q). 79.4 mg, 68%; Yellow solid; 1H NMR (500 MHz, CDCl3) δ 
8.08-7.96 (m, 1H), 7.93 (dd, J = 10.3, 9.0 Hz, 1H), 7.59-7.30 (m, 6H), 7.30-6.99 (m, 
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6H), 6.21 (q, J = 6.5 Hz, 1H), 5.49 (q, J = 6.4 Hz, 1H), 4.05 (q, J 
= 6.4 Hz, 2H), 1.96 (dd, J = 7.1, 1.9 Hz, 2H), 1.74 (td, J = 14.0, 
7.0 Hz, 2H), 1.57 (d, J = 6.5 Hz, 2H), 1.51-1.40 (m, 3H), 
1.40-1.23 (m, 8H), 0.95-0.81 (m, 4H); 13C NMR (125 MHz, 
CDCl3) δ 150.8, 150.7, 150.4, 149.7, 149.5, 147.7, 147.4, 143.41, 
143.35, 131.7, 131.6, 131.2, 130.5 (2C), 130.43, 130.41, 128.5, 
128.3, 128.0, 127.9, 127.8, 127.6, 126.6, 126.51, 126.45, 126.34, 
126.30, 126.26 (2C), 126.13, 126.12, 126.0, 57.3, 57.0, 56.9, 50.0, 48.6, 48.3, 32.7 
32.2, 29.8, 29.7, 27.7, 27.3, 27.2, 23.0, 16.9, 16.5, 14.4; IR (neat, / cm-1) 2925, 2124, 
1637, 1368, 1102, 698; HRMS (ESI+) Calcd for C32H40N3 [M+H]
+ 466.3222, Found 
466.3203. 
 
(E)-N-((E)-3-(tert-Butylimino)-2-ethylisoindolin-1-ylidene)octan-
1-amine (3r). 41.7 mg, 53%; Yellow oil; 1H NMR (500 MHz, 
CDCl3) δ 8.09 (d, J = 7.2 Hz, 1H), 8.01 (d, J = 7.2 Hz, 1H), 
7.55-7.45 (m, 2H), 3.92 (t, J = 7.1 Hz, 2H), 3.86 (q, J = 8.6 Hz, 2H), 
1.91-1.71 (m, 2H), 1.57-1.42 (m, 2H), 1.51 (s, 9H), 1.43-1.19 (m, 
8H), 1.11 (t, J = 8.6 Hz, 3H), 0.88 (t, J = 6.6 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 151.0, 147.1, 133.1, 130.9, 130.0, 129.6, 127.8, 126.1, 52.8, 50.1, 
34.0, 32.7, 32.1, 31.7, 29.8, 29.6, 27.8, 23.0, 14.4, 13.0; IR (KBr, / cm-1) 2965, 2927, 
2855, 1725, 1633, 1398, 1201, 1097, 678; HRMS (ESI+) Calcd for C22H36N3 [M+H]
+ 
342.2909, Found 342.2906. 
 
nOe correlation of 3r 
 
 
(E)-N-((E)-3-(Octylimino)-2-(4-(trifluoromethyl)phe
nyl)isoindolin-1-ylidene)-4-(trifluoromethyl)aniline 
(Inseparable mixture of isomers E/Z = 5:1) (3s). 114 
mg, 83%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 
8.09 (d, J = 7.7 Hz, 0.8H), 7.97 (d, J = 7.7 Hz, 0.2H), 7.76-7.54 (m, 6H), 7.35-7.32 (m, 
1H), 7.06-6.60 (m, 4H), 3.96 (t, J = 6.7 Hz, 1.7H), 2.99 (t, J = 6.7 Hz, 0.3H), 
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1.76-1.70 (m, 2H), 1.51-1.39 (m, 2H), 1.37-1.10 (m, 8H), 0.93-0.81 (m, 3H); 13C 
NMR (125 MHz, CDCl3) δ 153.0, 151.5, 151.0, 138.9, 132.3, 132.2, 131.2, 130.9, 
130.6, 130.2, 130.0, 129.9, 129.3, 129.0, 126.8, 126.6, 126.3, 125.8, 125.5, 125.2, 
123.6, 122.9, 120.8, 100.1, 50.3, 45.0, 32.1, 32.0, 31.9, 31.8, 30.0, 29.9, 29.6, 29.5, 
29.5, 29.5, 27.7, 27.5, 22.9, 14.4 [The coupling patterns derived from 19F atoms could 
not be analyzed because of the complexity of the signals.]; 19F NMR (376 MHz, 
CDCl3) δ -61.91, -61.97, -62.76, -62.80; IR (KBr, / cm-1) 2927, 1651, 1322, 1120, 
1066; HRMS (ESI+) Calcd for C30H30F6N3 [M+H]
+ 546.2344, Found 546.2317. 
 
(1Z,4Z)-Dimethyl N'1,N'4-dioctylterephthalimidate (4) 
1H NMR (500 MHz, CDCl3) δ 7.37 (s, 4H), 3.80 (s, 6H), 
3.24 (t, J = 7.1 Hz, 4H), 0.99-0.77 (m, 4H), 1.24 (s, 20H), 
0.86 (t, J = 6.8 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 
160.1, 133.6, 128.1, 53.1, 50.2, 32.2, 32.1, 31.8, 29.6, 
27.4, 22.9, 14.3; IR (KBr, / cm-1) 3075, 2916, 1509, 
1468, 1378, 1299, 1036; HRMS (ESI+) Calcd for C26H45N2O2 [M+H]
+ 416.3403, 
Found 416.3406. 
 
(N,N'E,N,N'E)-N,N'-((3E,7E)-2,6-Diisopropyl-3,7-bis(is
opropylimino)-2,3,6,7-tetrahydropyrrolo[3,4-f]isoindole
-1,5-diylidene)bis(octan-1-amine) (5). 1H NMR (500 
MHz, CDCl3) δ 8.63 (s, 2H), 4.90 (hept, J = 6.7 Hz, 2H), 
4.51 (hept, J = 5.6 Hz, 2H), 3.92 (t, J = 3.9 Hz, 4H), 
1.84-1.69 (m, 4H), 1.48 (d, J = 6.7 Hz, 12H), 1.37 (d, J = 
5.6 Hz, 12H), 1.52-1.43 (m, 4H), 1.39-1.24 (m, 16H), 0.89 (t, J = 6.7 Hz, 6H); 13C 
NMR (125 MHz, CDCl3) δ 150.1, 148.3, 132.9, 132.2, 123.4, 50.3, 49.0, 43.5, 32.7, 
32.2, 29.8, 29.7, 27.9, 25.3, 22.9, 19.5, 14.4; IR (KBr, / cm-1) 2972, 2915, 1685, 
1370, 1215, 1078; HRMS (ESI+) Calcd for C38H65N6 [M+H]
+ 605.5271, Found 
605.5247. 
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Iron-Catalyzed Acyloxyalkylation of Styrenes Using Hypervalent 
Iodine (III) Reagents 
 
General. All reactions were carried out in a dry solvent under an argon atmosphere.  
CH3CN was purchased from Kanto Co. and was dried and degassed before use. 
Fe(CO)3(cot) was purchased from Tokyo Kasei Kogyo Co. Styrenes (1d-1g, 1i-1m, 
and 1o-1r), iodobenzene carboxylates (2b and 2d-2k), and ligands (L6-L8) were 
prepared according to the literature methods.[[1]] Ligands (L4 and L5) were prepared 
according to general procedure. Iodobenzene carboxylates (2a and 2c) and ligands 
(L1-L3 and L9-L12) were purchased from Wako Co. and Sigma Aldrich Co. NMR 
spectra were recorded on JEOL ECX500 (500 MHz for 1H NMR and 125 MHz for 
13C NMR) and JEOL ECS400 (400 MHz for 1H NMR, 100 MHz for 13C NMR, 376 
MHz for 19F NMR) spectrometers. Proton chemical shifts are reported relative to 
Me4Si (CDCl3) at δ 0.00 ppm or residual solvent peak (CDCl3 at δ 7.26 ppm). Carbon 
chemical shifts are reported relative to CDCl3 at  77.26 ppm. Fluorine chemical 
shifts are reported relative to TFA (CDCl3) at -76.55 ppm as an external standard. 
Infrared (IR) spectra were recorded on a JASCO FT/IR 410 Fourier transform infrared 
spectrophotometer. ESI-mass spectra were measured on a JEOL JMS-T100LC 
AccuTOF spectrometer for HRMS.  
 
General Procedure for Preparation of Ligand (L4 and L5). 
 
To a Schlenk tube equipped with a stir bar was added 
4,7-dichloro-1,10-phenanthroline (49.8 mg, 0.200 mmol), arylboronic acid (0.440 
mmol, 2.2 equiv), Pd(dba)3·CHCl3 (10.4 mg, 0.0100 mmol, 5.0 mol%), 
tricyclohexylphosphine (2.8 mg, 0.010 mmol, 5.0 mol%), K3PO4 (170 mg, 4.0 equiv 
in water (1.0 mL)), and dioxane (1.0 mL). After the reaction mixture was allowed to 
stir at reflux for 24 h, the mixture was purified by column chromatography on silica 
gel to give a ligand in 70%-75% yield. 
 
General Procedure for Preparation of Styrenes.[1] To a 100 mL two-necked, 
round-bottomed flask charged a solution of Ph3MePBr (4.29 g, 12.0 mmol, 1.20 
equiv) in THF (40.0 mL) was added nBuLi (2.69 M, 4.46 mL, 12.0 mmol, 1.20 equiv) 
at 0 °C, and the mixture was stirred at 0 °C for 15 min. A solution of a ketone (10 
mmol, 1.0 equiv) was added at 0 °C. The reaction mixture was stirred at r.t. for 48 h. 
The resulting solution was quenched with aq. NH4Cl and the mixture was extracted 
with ethyl acetate (3 x 40 mL). The combined organic phases were dried over MgSO4, 
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concentrated in vacuo, and the residue was purified by column chromatography on 
silica gel to give styrene. 
 
General Procedure for Preparation of Iodobenzene Pentanoate 2b.[2] To a 100 mL 
round-bottom flask, PhI(OAc)2 (2a, 3.22 g, 10.0 mmol, 1.0 equiv) and pentanoic acid 
(1.63 g, 22.0 mmol, 2.2 equiv), and xylenes (50 mL) were added and the flask was 
operated on rotary evaporator at 65 ºC under reduced pressure (ca. 30-50 Torr or 4-6 
kPa). After xylenes was removed, the crude product was purified by recrystallization 
from hexane/dichloromethane to give product 2b as a white solid (3.05 g, 75%). 
 
Iodobenzene divalerate (2b). 3.05 g, 75%; Colorless soil; 1H 
NMR (500 MHz, CDCl3) δ 8.07 (d, J = 7.8 Hz, 2H), 7.58 (t, J 
= 7.4 Hz, 1H), 7.48 (dd, J = 7.8, 7.8 Hz, 2H), 2.35-2.12 (m, 
4H), 1.52 (tt, J = 7.6, 7.6 Hz, 4H), 1.26 (qt, J = 7.3, 7.3 Hz, 
4H), 0.85 (t, J = 7.4 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 
179.2, 135.1, 131.8, 131.1, 122.0, 34.0, 27.9, 22.5, 13.9; IR (neat, / cm-1) 3410, 2926, 
1539, 1412, 1105, 994, 727; HRMS (ESI+) Calcd for C16H23IO4 [M + Na]
+ 429.0533 
Found 429.0530. 
 
Iodobenzene dicyclopentanecarboxylate (2c). 2.58 g, 
60%; Colorless soil; 1H NMR (500 MHz, CDCl3) δ 8.05 
(d, J = 7.9 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.47 (dd, J = 
7.9, 7.9 Hz, 2H), 2.66 (tt, J = 7.5, 7.5 Hz, 2H), 1.87-1.36 
(m, 16H); 13C NMR (125 MHz, CDCl3) δ 182.0, 134.9, 
131.7, 131.0, 122.2, 43.9, 30.8, 26.0; IR (neat, / cm-1) 2927, 1650, 1508, 1110, 980, 
830, 750; HRMS (ESI+) Calcd for C18H23IO4 [M + Na]
+ 453.0533, Found 453.0517. 
 
Iodobenzene di(4,4,4-trifluorobutanoate) (2e). 
2.53 g, 52%; Colorless soil; 1H NMR (500 MHz, 
CDCl3) δ 8.07 (d, J = 8.0 Hz, 2H), 7.67-7.59 (m, 
1H), 7.57-7.46 (m, 2H), 2.54-7.47 (m, 4H), 
2.46-2.29 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 
175.8, 135.1, 132.4 131.4, 126.7 (q, J = 274 Hz), 122.0, 30.2 (q, J = 28.8 Hz), 26.8 (q, 
J = 6.3 Hz); 19F NMR (376 MHz, CDCl3) δ -67.8 (d, J = 11.7 Hz); IR (neat, / cm-1) 
2980, 2855, 1730, 1672, 1435, 1238, 1117, 1020, 784; HRMS (ESI+) Calcd for 
C14H13F6IO4 [M + Na]
+ 508.9655, Found 508.9560. 
 
 
Iodobenzene di(6-bromohexanoate) (2f). 754.8 mg, 15%; 
Colorless soil; 1H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 
8.0 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.48 (dd, J = 7.4, 7.4 
Hz, 2H), 3.47 (t, J = 6.6 Hz, 4H), 2.25 (t, J = 7.3 Hz, 4H), 
1.71 (tt, J = 7.2, 6.6 Hz, 4H), 1.55 (tt, J = 7.2, 7.7Hz, 4H), 1.37 (tt, J = 7.7, 7.3 Hz, 
4H); 13C NMR (125 MHz, CDCl3) δ 178.6, 135.0, 131.9, 131.1, 121.9, 45.0, 33.9, 
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32.3, 26.6, 25.0; IR (neat, / cm-1) 3515, 3081, 2957, 1729, 1629, 1148, 1127, 1072, 
763; HRMS (ESI+) Calcd for C18H25Cl2IO4 [M + Na]
+ 525.0067, Found 525.0052. 
 
Iodobenzene di(6-chlorohexanoate) (2g). 592.3 mg, 10%; 
Colorless soil; 1H NMR (500 MHz, CDCl3) δ 8.07 (d, J = 
8.4 Hz, 2H), 7.59 (t, J = 7.9 Hz, 1H), 7.49 (t, J = , 7.9 Hz, 
2H), 3.35 (t, J = 6.8 Hz, 4H), 2.26 (t, J = 7.4 Hz, 4H), 
1.82-1.64 (m,, 4H), 1.64-1.47 (m, 4H), 1.1.46-1.28 (m, 4H); 
13C NMR (125 MHz, CDCl3) δ 178.7, 135.2, 132.0, 131.2, 122.0, 34.0, 33.8, 32.6, 
27.9, 25.0; IR (neat, / cm-1) 2936, 2861, 1698, 1570, 1260, 1014, 733; MS (ESI+) 
Calcd for C18H25Br2IO4 [M + Na]
+ 612.9057, Found 612.9057. 
 
Iodobenzene di(6-iodohexanoate) (2h). 2.31 g, 60%; 
Colorless soil; 1H NMR (500 MHz, CDCl3) δ 8.09 (d, J = 7.4 
Hz, 2H), 7.60 (t, J = 7.4 Hz, 1H), 7.50 (t, J = 7.8 Hz, 2H), 3.14 
(t, J = 6.9 Hz, 4H), 2.27 (t, J = 7.4 Hz, 4H), 1.84-1.68 (m, 4H), 
1.61-1.51 (m, 4H), 1.42-1.28 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 178.7, 135.2, 
132.0, 131.2, 33.9, 33.3, 30.3, 24.8, 7.0; IR (neat, / cm-1) 3729, 1637, 1236, 992, 748, 
632; HRMS (ESI+) Calcd for C18H25I3O4 [M + Na]
+ 708.8779, Found 708.8790. 
 
Iodobenzene 
di(4-oxo-4-phenylbutanoate) (2i). 3.28 g, 
59%; Colorless soil; 1H NMR (500 MHz, 
CDCl3) δ 8.06-7.90 (m, 5H), 7.64-7.37 (m, 
10H), 3.33 (t, J = 6.6 Hz, 2H), 3.23 (t, J = 
6.6 Hz, 2H), 2.82 (t, J = 6.6 Hz, 2H), 2.71 (t, J = 6.6 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ 198.6, 177.8, 136.9, 135.0, 133.3, 131.8, 131.1, 128.8, 128.3, 121.8, 34.3, 
28.1; IR (neat, / cm-1) 3354, 3058, 2927, 1684, 1333, 1190, 994, 747; HRMS (ESI+) 
Calcd for C26H23IO6 [M + H]
+ 559.0612, Found 559.0584. 
 
Iodobenzene di(pent-4-enoate) (2j). 421.0 mg, 
10%; Colorless soil; 1H NMR (500 MHz, CDCl3) δ 
8.07 (d, J = 8.0 Hz, 2H), 7.59 (t, J = 7.8 Hz, 1H), 
7.49 (t, J = 7.7 Hz, 2H), 5.76 (td, J = 16.8, 6.3 Hz, 
2H), 5.05-4.88 (m, 4H), 2.36 (dd, J = 10.7, 4.3 Hz, 4H), 2.33-2.22 (m, 4H); 13C NMR 
(125 MHz, CDCl3) δ 178.2, 137.2, 135.1, 131.9, 131.1, 122.0, 115.5, 33.4, 29.8; IR 
(neat, / cm-1) 2970, 2958, 1635, 1420, 1390, 1230, 1138, 782; HRMS (ESI+) Calcd 
for C16H19IO4 [M + Na]
+ 425.0220, Found 425.0218. 
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Iodobenzene 
di(3-(4-chlorophenyl)propanoate) 
(2k). 3.54 g, 62%; Colorless soil; 1H 
NMR (500 MHz, CDCl3) δ 7.91 (d, J = 
8.1 Hz, 2H), 7.59 (t, J = 7.0 Hz, 1H), 
7.45 (dd, J = 8.1, 7.0 Hz, 2H), 7.20 (d, 
J = 8.2 Hz, 4H), 7.05 (d, J = 8.2 Hz, 4H), 2.83 (t, J = 7.5 Hz, 4H), 2.55 (t, J = 7.5 Hz, 
4H); 13C NMR (125 MHz, CDCl3) δ 177.7, 139.4, 135.0, 132.1, 132.0, 131.1, 129.9, 
128.7, 121.8, 35.5, 31.2; IR (neat, / cm-1) 2934, 1648, 1490, 1473, 1370, 1190, 1088, 
740; HRMS (ESI+) Calcd for C24H21Cl2IO4 [M + Na]
+ 592.9754, Found 592.9758. 
 
Iodobenzene di(2-(p-tolyl)acetate) (2l). 3.68 
g, 73%; Colorless soil; 1H NMR (500 MHz, 
CDCl3) δ 7.95 (d, J = 8.2 Hz, 2H), 7.56 (t, J = 
7.4 Hz, 1H), 7.43 (dd, J = 8.2, 7.4 Hz, 2H), 
7.20-7.30 (m, 8H), 3.54 (s, 4H), 2.32 (s, 6H); 
13C NMR (125 MHz, CDCl3) δ 176.7, 136.6, 134.8, 131.9, 131.8, 131.0, 129.3, 129.2, 
122.2, 40.8, 21.3; IR (neat, / cm-1) 2990, 2873, 1447, 1730, 1583, 1057, 960, 796; 
HRMS (ESI+) Calcd for C24H23IO4 [M + Na]
+ 525.0533, Found 525.0538. 
 
Typical Procedure for Oxyalkylation of Styrene 1a. A mixture of 
1-(tert-butyl)-4-vinylbenzene (1a, 40.1 mg, 0.250 mmol), Iodobenzene diacetate (2a, 
104.7 mg, 0.325 mmol, 1.3 equiv), Fe(CO)3(cot) (6.1 mg, 0.025 mmol, 10 mol%), L4 
(bathocuproine, 9.0 mg, 0.025 mmol, 10 mol%), and CH3CN (1.0 mL) was stirred at 
70 °C for 12 h in a sealed tube. Then, the solvent was removed in vacuo and the 
product was isolated by column chromatography on silica gel (n-hexane/EtOAc = 
20:1) to give 1-(4-(tert-butyl)phenyl)propyl acetate (3aa, 31.0 mg, 53% yield).  
 
1-(4-(tert-Butyl)phenyl)propyl acetate (3aa).[4] 31.0 mg, 
53%; Colorless oil; 1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 
7.8 Hz, 2H), 7.18 (d, J = 7.8 Hz, 2H), 5.58 (t, J = 6.7 Hz, 1H), 
1.99 (s, 3H), 1.90-1.68 (m, 2H), 1.23 (s, 9H), 0.81 (t, J = 7.2 
Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 170.8, 151.0, 137.7, 
126.5, 125.5, 77.5, 34.8, 31.6, 29.4, 21.6, 10.3. 
 
1-(4-Methoxyphenyl)propyl acetate (3ba).[4] 40.0 mg, 71%; 
Yellow oil; 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.7 Hz, 
2H), 6.87 (d, J = 8.7 Hz, 2H), 5.61 (t, J = 7.0 Hz, 1H), 3.80 (s, 
3H), 2.05 (s, 3H), 1.96-1.74 (m, 2H), 0.86 (t, J = 7.4 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 170.7, 159.4, 132.8, 128.3, 114.0 ,77.4, 55.5, 29.3, 
21.6, 10.2. 
 
1-([1,1'-Biphenyl]-4-yl)propyl acetate (3ca).[4] 29.2 mg, 46%;  
Colorless soil; 1H NMR (500 MHz, CDCl3) δ 7.62-7.56 (m, 4H), 
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7.48-7.38 (m, 4H), 7.38-7.32 (m, 1H), 5.72 (t, J = 6.9 Hz, 1H), 2.09 (s, 3H), 2.2-1.81 
(m, 2H), 0.93 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 170.7, 141.0, 139.8, 
129.0, 127.5, 127.4, 127.3, 127.3, 77.4, 29.5, 21.5, 10.2.  
 
2-Phenylbutan-2-yl acetate (3da).[5] 22.1 mg, 46%; Yellow oil; 1H 
NMR (500 MHz, CDCl3) δ 7.38-7.28 (m, 4H), 7.25-7.20 (m, 1H), 
2.07 (s, 3H), 1.85-1.75 (m, 2H), 1.82 (s, 3H), 0.79 (t, J = 7.4 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 170.0, 145.1, 128.4, 127.0, 
124.9, 84.6, 35.4, 24.6, 22.5, 8.4. 
 
2-(3,4,5-Timethoxyphenyl)butan-2-yl acetate (3ea). 44.4 
mg, 63%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 6.50 (s, 
2H), 3.85 (s, 6H), 3.82 (s, 3H), 2.07 (s, 3H), 2.04-1.94 (m, 
2H), 1.79 (s, 3H), 0.80 (t, J = 7.4 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 169.9, 153.1, 141.1, 137.0, 102.4, 84.6, 61.0 
56.3, 35.4, 24.5 22.5 8.5; IR (neat, / cm-1) 2974, 1736, 1589, 1413, 1244, 1126, 
1012829, 772; HRMS (ESI+) Calcd for C15H22O5 [M + Na]
+ 305.1359, Found 
305.1347. 
 
4-(2-Aetoxybutan-2-yl)phenyl acetate (3fa). 33.9 mg, 54%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.30 (d, J = 8.6 Hz, 
2H), 7.05 (d, J = 8.6 Hz, 2H), 2.28 (s, 3H), 2.06 (s, 3H), 
2.10-1.95 (m, 2H), 1.80 (s, 3H), 0.79 (t, J = 7.4 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 169.9, 169.6, 149.6, 142.6, 126.0, 121.3, 84.2, 35.2, 24.7, 
22.4, 21.4, 8.3; IR (neat, / cm-1) 2980, 1375, 1508, 1369, 1202, 1016, 912; HRMS 
(ESI+) Calcd for C14H18O4 [M + Na]
+ 273.1097, Found 273.1103. 
 
2-(4-Fluorophenyl)butan-2-yl acetate (3ga). 26.8 mg, 51%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.27 (dd, J = 8.7 Hz, 
2H), 7.00 (dd, J = 8.7, 8.7 Hz, 2H), 2.05 (s, 3H), 2.00 (q, J = 7.3 
Hz, 2H), 1.80 (s, 3H), 0.78 (t, J = 7.3 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 169.9, 161.8 (d, J = 244 Hz), 140.9 (d, J = 2.5 Hz)，126.6 (d, J = 7.5 
Hz)，115.2 (d, J = 21.3 Hz)，84.1, 35.4, 24.5, 22.4, 8.3; 19F NMR (376 MHz, CDCl3) 
δ -117.2; IR (neat, / cm-1) 2973, 1733, 1487, 1105, 1245, 1090, 717; HRMS (ESI+) 
Calcd for C12H15FO2 [M + Na]
+ 233.09483, Found 233.0947. 
 
2-(4-Chlorophenyl)butan-2-yl acetate (3ha). 39.1 mg, 69%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.29 (d, J = 8.6 Hz, 
2H), 7.23 (d, J = 8.6 Hz, 2H), 2.06 (s, 3H), 2.03-1.95 (m, 2H), 
1.79 (s, 3H), 0.78 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 169.9, 143.7, 132.8, 128.5, 126.4, 84.0, 35.3, 24.4, 22.4, 8.3; IR (neat, / 
cm-1) 2976, 1736, 1367, 1243, 1008, 816.; HRMS (ESI+) Calcd for C12H15ClO2 [M + 
Na]+ 249.0653, Found 249.0639. 
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2-(4-Bromophenyl)butan-2-yl acetate (3ia). 46.3 mg, 68%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.44 (d, J = 8.6 Hz, 
2H), 7.17 (d, J = 8.6 Hz, 2H), 2.06 (s, 3H), 2.01-1.95 (m, 2H), 
1.78 (s, 3H), 0.78 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) 169.9, 144.2, 131.5, 126.8, 121.0, 84.0, 35.3, 24.4, 22.4, 8.3; IR (neat, / 
cm-1) 2975, 2938, 1737, 1492, 1368, 1243, 1012, 820; HRMS (ESI+) Calcd for 
C12H15BrO2 [M + Na]
+ 293.0148 Found 293.0149. 
 
2-(4-Iodophenyl)butan-2-yl acetate (3ja). 51.6 mg, 65%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.64 (d, J = 7.0 Hz, 
2H), 7.05 (d, J = 7.0 Hz, 2H), 2.06 (s, 3H), 1.98 (q, J = 7.4 Hz, 
2H), 1.77 (s, 3H), 0.78 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 170.0, 144.9, 137.5, 127.0, 92.6, 84.1, 35.3, 24.3, 22.4, 8.3; IR (neat, / 
cm-1) 2973, 1735, 1366, 1243, 1003, 942, 814; HRMS (ESI+) Calcd for C12H15IO2 [M 
+ Na]+ 341.0009, Found 341.0024. 
 
2-(Naphthalen-2-yl)butan-2-yl acetate (3ka).[6] 32.7 mg, 
54%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.89-7.80 (m, 
3H), 7.78 (s, 1H), 7.53-7.41 (m, 3H), 2.20-2.14 (m, 2H), 2.13 
(s, 3H), 1.95 (s, 3H), 0.83 (t, J = 7.4 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 170.0, 142.4, 133.3, 132.6, 128.4, 128.2, 127.7, 126.2, 126.0, 123.7, 
123.3, 84.7, 35.2, 24.5, 22.5, 8.4. 
 
3-Phenylheptan-3-yl acetate (3la). 28.6 mg, 49%; Yellow oil; 1H 
NMR (500 MHz, CDCl3) δ 7.33-7.22 (m, 4H), 7.22-7.11 (m, 1H), 
2.41-2.24 (m, 2H), 2.06 (s, 3H), 2.04-1.89 (m, 2H), 1.22-1.10 (m, 
2H), 1.10-0.84 (m, 2H), 0.76 (t, J = 7.4 Hz, 3H), 0.62 (t, J = 7.4 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 169.7, 143.9, 128.2, 126.8, 125.3, 87.9, 37.6, 
30.9, 25.6, 23.0, 22.3, 14.2, 7.9; IR (neat, / cm-1) 2934, 1735, 1366, 1245, 1016, 700; 
HRMS (ESI+) Calcd for C15H22O2 [M + Na]
+ 257.1512, Found 257.1518. 
 
1,2-Diphenylbutan-2-yl acetate (3ma). 28.4 mg, 42%; Yellow oil; 
1H NMR (500 MHz, CDCl3) δ 7.33-7.17 (m, 5H), 7.17-7.07 (m, 
3H), 6.75 (d, J = 6.8 Hz, 2H), 3.58 (d, J = 13.6 Hz, 1H), 3.37 (d, J 
= 13.6 Hz, 1H), 2.49 (dq, J = 14.7, 7.4 Hz, 1H), 2.21 (dq, J = 14.7, 
7.4 Hz, 1H), 0.79 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 170.1, 143.1, 
136.4, 130.6, 128.2, 127.9, 127.1, 126.6, 125.7, 87.5, 44.2, 29.9, 22.5, 8.0; IR (neat, / 
cm-1) 2970, 1735, 1366, 1231, 1021, 700; HRMS (ESI+) Calcd for C18H20O2 [M + 
Na]+ 291.1356, Found 291.1352. 
 
1,1-Diphenylpropyl acetate (3na). 46.4 mg, 73%; Colorless soil; 
1H NMR (500 MHz, CDCl3) δ 7.34-7.28 (m, 4H), 7.28-7.22 (m, 4H), 
7.22-7.14 (m, 2H), 2.75 (q, J = 7.3 Hz, 2H), 2.11 (s, 3H), 0.72 (t, J = 
7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 169.1, 145.0, 128.2, 
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127.1, 126.2, 87.0, 29.8, 22.3 7.7; IR (neat, / m-1) 3512, 3059, 2974, 1953, 1717, 
1448, 1252, 970, 763, 763; HRMS (ESI+) Calcd for C17H18O2 [M + H]
+ 277.1199, 
Found 277.1209. 
 
1-(3,4-Difluorophenyl)-1-phenylpropyl acetate (3oa). 48.2 mg, 
67%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.31-7.23 (m, 
4H), 7.23-7.17 (m, 1H), 7.13 (ddd, J = 11.7, 7.6, 2.0 Hz, 1H), 
7.07-6.96 (m, 2H), 2.69 (q, J = 7.3 Hz, 2H), 2.11 (s, 3H), 0.70 (t, 
J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 168.9, 149.8 
(dd, J = 248, 99.5 Hz), 149.7 (dd, J = 248, 99.5 Hz), 144.2, 142.3 (dd, J = 5.0, 3.8 
Hz,), 128.5, 127.5, 126.1, 122.4 (dd, J = 6.3, 3.8 Hz), 117.0 (d, J = 17.2 Hz), 115.8 (d, 
J = 18.6 Hz), 86.1, 29.8, 22.2, 7.7; 19F NMR (376 MHz, CDCl3) δ -138.4, -141.0; IR 
(neat, / cm-1) 3445, 2976, 1738, 1608, 1517, 1370, 1253, 1018, 867, 775; HRMS 
(ESI+) Calcd for C17H16F2O2 [M + Na]
+ 313.1011, Found 313.1024. 
 
1-(4-Chlorophenyl)-1-phenylpropyl acetate (3pa). 48.2 mg, 
67%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.37-7.11 (m, 
9H), 2.72 (q, J = 7.3 Hz, 2H), 2.11 (s, 3H), 0.71 (t, J = 7.3 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 169.0, 144.5, 143.7, 
133.0, 128.43, 128.35, 127.8, 127.3, 126.2, 86.6, 29.8, 22.3, 
7.7; IR (neat, / cm-1) 3081, 1983, 1598, 1372, 970, 639; 
HRMS (ESI+) Calcd for C17H17ClO2 [M + Na]
+ 311.0809, Found 311.0804. 
 
2-(Benzofuran-2-yl)butan-2-yl acetate (3qa). 38.1 mg, 66%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.53 (d, J = 7.6 Hz, 
1H), 7.44 (d, J = 8.2 Hz, 1H), 7.31-7.45 (m, 2H), 6.62 (s, 1H), 
2.28-2.08 (m, 2H), 2.06 (s, 3H), 1.86 (s, 3H), 0.87 (t, J = 7.5 
Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 169.9, 158.8, 154.7, 128.4, 124.1, 122.9, 
121.3, 111.4, 103.2, 80.5, 32.3, 22.6, 22.2, 8.3; IR (neat, / cm-1) 3471, 2972, 1740, 
1455, 1242, 1017, 941, 751; HRMS (ESI+) Calcd for C14H16O3 [M + Na]
+ 255.0992, 
Found 255.0980. 
 
2-(Thiophen-3-yl)butan-2-yl acetate (3ra). 25.5 mg, 51%; Yellow oil; 
1H NMR (500 MHz, CDCl3) δ 7.21-7.16 (m, 1H), 7.05-7.01 (m, 1H), 
6.92 (d, J = 4.8 Hz, 1H), 2.07-1.97 (m, 2H), 1.96 (s, 3H), 1.73 (s, 3H), 
0.72 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 170.0, 146.4, 
125.6, 120.2, 83.2, 34.5, 25.0, 22.5, 8.38; IR (neat, / cm-1) 3446, 2968, 
1731, 1675, 1456, 1258, 1082, 791, 663; HRMS (ESI+) Calcd for C10H17O2S [M + 
Na]+ 221.0607, Found 221.0603. 
 
1-(4-Methoxyphenyl)hexyl pentanoate (3bb). 46.2 mg, 63%; 
Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.31-7.22 (m, 2H), 
6.87 (d, J = 8.7 Hz, 2H), 5.70 (t, J = 7.1 Hz, 1H), 3.81 (s, 3H), 
2.38-2.23 (m, 2H), 1.96-1.84 (m, 1H), 1.80-1.68 (m, 1H), 1.60 
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(tt, J = 7.4 Hz, 2H), 1.41-1.12 (m, 8H), 0.97-0.80 (m, 6H); 13C NMR (125 MHz, 
CDCl3) δ 173.5, 159.4, 133.4, 128.2, 113.9, 75.8, 55.5, 36.4, 34.6, 31.7, 27.3, 25.5, 
22.7, 22.5, 14.2, 14.0; IR (neat, / cm-1) 2957, 2932, 1733. 1613, 1514, 1248, 1171, 
830, 730; HRMS (ESI+) Calcd for C18H28O3 [M + Na]
+ 315.1931, Found 315.1942. 
 
Procedure for gram scale. A mixture of 1-(tert-butyl)-4-vinylbenzene (1a, 1.71 g, 
10.7 mmol), iodobenzene diacetate (2a, 4.47 g, 13.9 mmol), Fe(CO)3(cot) (0.260 g, 
1.07 mmol), L10 (bathocuproine, 0.385 g, 1.07 mmol), and CH3CN (46.0 mL) was 
stirred at 70 °C for 12 h in a sealed tube. Then, the solvent was removed in vacuo and 
the product was isolated by column chromatography on silica gel (n-hexane/EtOAc = 
20:1) to give 1-(4-(tert-butyl)phenyl)propyl acetate (3aa, 1.15 g, 46% yield). 
 
2-Cyclopentyl-1-(4-methoxyphenyl)ethyl 
cyclopentanecarboxylate (3bc). 64.7 mg, 82%; Yellow oil; 
1H NMR (500 MHz, CDCl3) δ 7.19 (dd, J = 8.7, 2.1 Hz, 
2H), 6.78 (dd, J = 8.7, 2.1 Hz, 2H), 5.62 (t, J = 7.1 Hz, 1H), 
3.71 (s, 3H), 2.72-2.58 (m, 1H), 1.95-1.25 (m, 17H), 
1.15-0.93 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 176.2, 
159.3, 133.6, 128.1, 113.9, 75.3, 55.4, 44.3, 42.8, 36.8, 33.0, 32.8, 30.1, 30.0, 26.01, 
25.97, 25.3, 25.2; IR (neat, / cm-1) 2951, 2868, 1729, 1613, 1453, 1248, 1173, 1037, 
830; HRMS (ESI+) Calcd for C20H28O3 [M + Na]
+ 339.1931, Found 339.1941. 
 
1-(4-Methoxyphenyl)-3,3-dimethylbutyl pivalate (3bd). 48.5 
mg, 66%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.23 (d, J 
= 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 5.77 (dd, J = 8.9, 3.2 
Hz, 1H), 3.78 (s, 3H), 2.02-1.91 (m, 1H), 1.57 (dd, J = 14.8, 
3.3 Hz, 1H), 1.15 (s, 9H), 0.94 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 177.8, 159.1, 
135.4, 127.6, 114.0, 73.8, 55.4, 50.4, 38.8, 30.6, 30.2, 27.3; IR (neat, / cm-1) 3401, 
2935, 1733, 1589, 1508, 1246, 1126, 831, 643; HRMS (ESI+) Calcd for C18H28O3 [M 
+ Na]+ 315.1931, Found 315.1942. 
 
1-Methoxy-4-(5,5,5-trifluoro-3-methylene-1-((4,4,4-tri
fluorobut-1-en-2-yl)peroxy)pentyl)benzene (3be). 74.5 
mg, 80%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 
7.25 (d, J = 8.8 Hz, 2H), 6.89 (d, J = 8.8 Hz, 2H), 5.71 (t, 
J = 7.1 Hz, 1H), 3.81 (s, 3H), 2.70-2.51 (m, 2H), 
2.51-2.36 (m, 2H), 2.15-2.03 (m, 2H), 2.03-1.95 (m, 1H), 
1.78-1.90 (m, 1H), 1.68-1.55 (m, 1H), 1.55-1.43 (m, 1H); 13C NMR (125 MHz, 
CDCl3) δ 170.5, 159.9, 131.7, 128.1, 127.0 (q, J = 253 Hz), 126.7 (q, J = 276 Hz), 
114.3, 76.2, 55.5, 35.1, 33.5 (q, J = 29.0 Hz), 29.5 (q, J = 30.2 Hz), 27.6, 18.5; 19F 
NMR (376 MHz, CDCl3) δ -67.2 (t, J = 10.9 Hz, 3F), -67.8 (t, J = 10.4 Hz, 3F), IR 
(neat, / cm-1) 2959, 1740, 1613, 1515, 1331, 1251, 1109, 831, 626; HRMS (ESI+) 
Calcd for C16H18F6O3 [M + Na]
+ 395.1052, Found 395.1043. 
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7-Chloro-1-(4-methoxyphenyl)heptyl 
6-chlorohexanoate (3bf). 63.3 mg, 65% Yellow oil; 1H 
NMR (500 MHz, CDCl3) δ 7.27 (d, J = 8.7 Hz, 2H), 
6.88 (d, J = 8.7 Hz, 2H), 5.70 (t, J = 7.0 Hz, 1H), 3.81 
(s, 3H), 3.57-3.45 (m, 4H), 2.39-2.25 (m, 2H), 
1.98-1.86 (m, 1H), 1.82-1.69 (m, 5H), 1.6-1.56 (m, 2H), 
1.52-1.14 (m, 8H); 13C NMR (125 MHz, CDCl3) δ 
173.0, 159.4, 133.0, 128.1, 114.0, 75.8, 55.4, 45.2, 45.0, 
36.1, 34.5, 32.7, 32.4, 28.7, 26.9, 26.5, 25.6, 24.4; IR (neat, / cm-1) 2935, 2859, 1731, 
1612, 1514, 1248, 1035, 831, 729, 649; HRMS (ESI+) Calcd for C20H30Cl2O3[M + 
Na]+ 411.1464, Found 411.1472. 
 
7-Bromo-1-(4-methoxyphenyl)heptyl 
6-bromohexanoate (3bg). 81.0 mg, 68% Yellow oil; 
1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 8.6 Hz, 2H), 
6.87 (d, J = 8.6 Hz, 2H), 5.68 (t, J = 7.0 Hz, 1H), 3.80 
(s, 3H), 3.46-3.27 (m, 4H), 2.42-2.16 (m, 2H), 
2.04-1.71 (m, 6H), 1.71-1.52 (m, 2H), 1.52-1.09 (m, 
8H); 13C NMR (125 MHz, CDCl3) δ 173.0, 159.4, 
133.0, 128.2, 114.0, 75.9, 55.5, 36.2, 34.6, 34.1, 33.7, 
32.9, 32.6, 28.6, 28.2, 27.8, 25.6, 24.3; IR (neat, / 
cm-1) 2935, 2857, 1731, 1513, 1461, 1248, 1174, 1034, 831, 732; HRMS (ESI+) Calcd 
for C20H30Br2O3[M + Na]
+ 499.0454, Found 499.0451. 
 
7-Iodo-1-(4-methoxyphenyl)heptyl 6-iodohexanoate 
(3bh). 64.4 mg, 45% Yellow oil; 1H NMR (500 MHz, 
CDCl3) δ 7.27 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.6 Hz, 
2H), 5.70 (t, J = 7.0 Hz, 1H), 3.81 (s, 3H), 3.24-307(m, 
4H), 2.39-2.25 (m, 2H), 1.99-1.87 (m, 1H), 1.87-1.72 (m, 
5H), 1.69-1.56 (m, 2H), 1.47-1.28 (m, 7H), 1.28-1.18 (m, 
1H); 13C NMR (125 MHz, CDCl3) δ 172.9, 159.4, 132.9, 
128.1, 114.0, 75.8, 55.4, 36.1, 34.5, 33.5, 33.3, 30.5, 
30.1, 28.4, 25.6, 24.1, 7.4, 6.8; IR (neat, / cm-1) 2938, 
2870, 1671, 1370, 1302, 922, 830 HRMS (ESI+) Calcd for C20H30I2O3[M + Na]
+ 
595.0177, Found 595.0187. 
 
5-(4-Methoxyphenyl)-5-((4-oxo-4-phenylbut-1-en-2-
yl)peroxy)-1-phenylpentan-1-one (3bi). 46.3 mg, 
42%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 
8.01-7.87 (m, 4H), 7.62-7.51 (m, 2H), 7.45 (dd, J = 7.6, 
7.6 Hz, 4H), 7.27 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 
Hz, 2H), 5.76 (t, J = 6.8 Hz, 1H), 3.79 (s, 3H), 
3.41-3.20 (m, 2H), 2.98 (t, J = 7.1 Hz, 2H), 2.90-2.79 (m, 1H), 2.79-2.67 (m, 1H), 
2.11-1.96 (m, 1H), 1.94-1.75 (m, 2H), 1.75-1.64 (m, 1H); 13C NMR (125 MHz, 
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CDCl3) δ 200.0, 198.3, 172.5, 159.5, 137.1, 136.8, 133.4, 133.2, 132.6, 128.82, 
128.80, 128.3, 128.24, 128.18 114.1, 76.0, 55.5, 38.2, 35.7, 33.6, 28.8, 20.4; IR (neat, 
/ cm-1) 2932, 1731, 1684, 1514, 1248, 1167, 1033, 831, 691; HRMS (ESI+) Calcd for 
C28H28O5 [M + Na]
+ 467.1829, Found 467.1828. 
 
1-(4-methoxyphenyl)hex-5-en-1-yl pent-4-enoate (3bj). 
432.8 45; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 7.27 
(d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.8 Hz, 2H), 5.89-5.68 
(m, 3H), 5.07-4.92 (m, 4H), 3.79 (s, 3H), 2.47-2.30 (m, 
4H), 2.11-2.01 (m, 2H), 1.99-1.87 (m, 1H), 1.86-1.71 (m, 
1H), 1.51-1.37 (m, 1H), 1.37-1.23 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 172.5, 
159.4, 138.5, 136.8, 133.0, 128.1, 115.6, 115.0, 114.0, 75.8, 55.4, 35.7, 34.0, 33.5, 
29.1, 25.0; IR (neat, / cm-1) 2938, 2842 1780, 1520, 1090, 718, 700; HRMS (ESI+) 
Calcd for C16H24O3 [M + Na]
+ 311.3762, Found 311.3775. 
 
4-(4-Chlorophenyl)-1-(4-methoxyphenyl)butyl 
3-(4-chlorophenyl)propanoate (3bk). 83.5 mg, 
73%; Yellow oil; 1H NMR (500 MHz, CDCl3) δ 
7.37-7.21 (m, 6H), 7.14 (d, J = 8.4 Hz, 2H), 7.12 
(d, J = 8.4 Hz, 2H), 6.93 (d, J = 8.4 Hz, 2H), 5.78 
(t, J = 7.0 Hz, 1H), 3.87 (s, 3H), 2.96 (t, J = 7.7 Hz, 
2H), 2.72-2.59 (m, 4H), 2.02-1.89 (m, 1H), 
1.89-1.77 (m, 1H), 1.71-1.44 (m, 2H); 13C NMR 
(125 MHz, CDCl3) δ 172.1, 159.5, 140.5, 139.0, 
132.5, 132.1, 131.7, 129.91, 129.87, 128.7, 128.6, 128.1, 114.0, 75.9, 55.4, 36.1, 35.6, 
35.0, 30.4, 27.4; IR (neat, / cm-1) 3445, 2935, 1731, 1612, 1514, 1302, 1248, 1035, 
831, 729, 649; HRMS (ESI+) Calcd for C26H26Cl2O3 [M + Na]
+ 479.1151, Found 
479.1529. 
 
1-(4-Methoxyphenyl)-3-(p-tolyl)propyl 
2-(p-tolyl)acetate (3bl). 50.3 mg, 52% Yellow oil; 1H 
NMR (500 MHz, CDCl3) δ 7.30-7.21 (m, 2H), 
7.21-7.11 (m, 4H), 7.08 (d, J = 7.8 Hz, 2H), 6.98 (d, J 
= 7.8 Hz, 2H), 6.87 (dd, J = 8.8, 2.4 Hz, 2H), 5.71 (t, J 
= 6.8 Hz, 1H), 3.81 (s, 3H), 3.59 (s, 3H), 2.59-2.40 (m, 
2H), 2.35 (s, 3H), 2.32 (s, 3H); 2.27-2.16 (m, 1H), 
2.08-1.98 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 171.2, 159.5, 138.3, 136.8, 135.6, 
132.7, 131.3, 129.42, 129.36, 129.3, 128.4, 128.2, 114.0, 75.8, 55.5, 41.5, 38.1, 31.5, 
21.3, 21.2; IR (neat, / cm-1) 2923, 1733, 1514, 1248, 1033, 808; HRMS (ESI+) Calcd 
for C26H28O3 [M + Na]
+ 411.4962, Found 411.4970. 
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